These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
ý
|
||
|
Filed by a Party other than the Registrant
o
|
||
|
Check the appropriate box:
|
||
|
o
|
Preliminary Proxy Statement
|
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
ý
|
Definitive Proxy Statement
|
|
|
o
|
Definitive Additional Materials
|
|
|
o
|
Soliciting Material Pursuant to §240.14a-12
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
|
|
ý
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
(1) Title of each class of securities to which transaction applies:
|
|
|
(2) Aggregate number of securities to which transaction applies:
|
|
|
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4) Proposed maximum aggregate value of transaction:
|
|
|
(5) Total fee paid:
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1) Amount Previously Paid:
|
|
|
(2) Form, Schedule or Registration Statement No.:
|
|
|
(3) Filing Party:
|
|
|
(4) Date Filed:
|
|
1.
|
To elect the eight directors named in the proxy statement;
|
|
2.
|
To approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement;
|
|
3.
|
To approve (i) an amendment and restatement of the Company’s Equity and Long-Term Incentive Plan (the “ELTIP”) to increase the aggregate number of shares authorized for issuance under the ELTIP by 50 million shares and (ii) the material terms of the performance goals under the ELTIP for the purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”);
|
|
4.
|
To approve (i) an amendment and restatement of the Company’s Annual Performance Plan (the “APP”) and (ii) the material terms of the performance goals under the Company’s APP for the purposes of Section 162(m) of the Code;
|
|
5.
|
To ratify the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditor for the fiscal year ending June 30, 2017; and
|
|
6.
|
To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
|
|
|
By order of the Board of Directors,
|
|
|
|
|
|
|
|
|
|
|
|
Jules P. Kaufman
|
|
|
|
|
|
Senior Vice President, General Counsel and Secretary
|
||
|
Table of Contents
|
|
|
|
|
|
Questions and Answers about the Proxy Materials and the Annual Meeting
|
|
|
Corporate Governance
|
|
|
Structure of our Board
|
|
|
Board Meetings
|
|
|
Board Qualifications and Membership Criteria
|
|
|
Director Nomination Process
|
|
|
Director Independence
|
|
|
Communications with our Board
|
|
|
Our Board’s Role in Risk Oversight
|
|
|
Board Attendance at the Annual Meeting
|
|
|
Compensation Committee Interlocks and Insider Participation
|
|
|
Certain Relationships and Related Party Transactions
|
|
|
Proposal No. 1: Election of Directors
|
|
|
Director Nominees
|
|
|
Director Compensation
|
|
|
Executive Officers
|
|
|
Security Ownership of Certain Beneficial Owners and Management
|
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
|
|
Proposal No. 2: Approval of Advisory Resolution on NEO Compensation (Say-On-Pay)
|
|
|
Compensation Discussion and Analysis
|
|
|
Remuneration and Nomination Committee Report
|
|
|
Proposal No. 3: Approval of an Amendment and Restatement of the Equity and Long-Term Incentive Plan and the Material Terms of the Performance Goals Under the Plan
|
|
|
Proposal No. 4: Approval of an Amendment and Restatement of the Annual Performance Plan and the Material Terms of the Performance Goals Under the Plan
|
|
|
Proposal No. 5: Ratification of Appointment of Deloitte & Touche LLP as our Independent Auditor
|
|
|
Audit Fees and Other Fees
|
|
|
Audit and Finance Committee Report
|
|
|
Stockholder Proposals for the 2017 Annual Meeting
|
|
|
Other Matters
|
|
|
Annex A – Amended and Restated Coty Inc. Equity and Long-Term Incentive Plan
|
|
|
Annex B – Amended and Restated Coty Inc. Annual Performance Plan
|
|
|
Proposal
|
|
Voting
Options
|
|
Vote Required to Adopt the Proposal
|
|
Effect of Abstentions or Withhold Votes (for Director Elections)
|
|
Effect of “Broker
Non-Votes”
|
|
Board Recommendation
|
|
Proposal 1: Election of Directors
|
|
For All,
Withhold All, or For All Except.
|
|
A plurality of votes - nominees receiving the highest number of affirmative votes will be elected (up to the total number of available board seats).
|
|
No effect.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
each director.
|
|
Proposal 2: Approval of Advisory Resolution on Named Executive Officer (“NEO”) Compensation
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
No effect.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
the approval of the advisory resolution on NEO compensation.
|
|
Proposal 3: Approval of an Amendment and Restatement of the ELTIP and the Material Terms of the Performance Goals under the ELTIP
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
Effect of a vote “against” because abstentions are treated as votes “cast” under the applicable New York Stock Exchange (the “NYSE”) requirements.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
the approval of the amendment and restatement of the ELTIP and the material terms of the performance goals under the ELTIP.
|
|
Proposal 4: Approval of an Amendment and Restatement of the APP and the Material Terms of the Performance Goals under the APP
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
No effect.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
the approval of the amendment and restatement of the APP and the material terms of the performance goals under the APP.
|
|
Proposal 5: Ratification of Appointment of Deloitte & Touche LLP (“Deloitte”) as our independent auditor
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
No effect.
|
|
Brokers have discretion to vote.
|
|
Our Board recommends a vote
FOR
ratification.
|
|
1.
|
FOR the election of each nominee as director;
|
|
2.
|
FOR the advisory resolution on the compensation of our NEOs;
|
|
3.
|
FOR the approval of (i) an amendment and restatement of the ELTIP to increase the aggregate number of shares authorized for issuance under the ELTIP by 50 million shares and (ii) the material terms of the performance goals under the ELTIP for the purposes of Section 162(m) of the Code;
|
|
4.
|
FOR the approval of (i) an amendment and restatement of the APP and (ii) the material terms of the performance goals under the APP for the purposes of Section 162(m) of the Code; and
|
|
5.
|
FOR the ratification of the appointment of Deloitte as independent auditor.
|
|
•
|
giving written notice to our Corporate Secretary revoking your proxy;
|
|
•
|
by submitting a later-dated proxy by telephone or electronically before 11:59 p.m. EDT on November 2, 2016;
|
|
•
|
by a later-dated mailed proxy received before the close of the Annual Meeting on November 3, 2016; or
|
|
•
|
by voting online at the Annual Meeting.
|
|
•
|
monitoring the integrity of our financial reporting process and systems of internal controls regarding finance, accounting, and compliance with our Code and laws and regulations;
|
|
•
|
being responsible for the appointment, compensation, retention and oversight of the work of our independent auditors and assessing and monitoring the independence and performance of our independent auditors and internal audit department;
|
|
•
|
providing an objective, direct communication between our Board, independent auditors, management and the internal audit department;
|
|
•
|
reviewing and pre-approving both audit and non-audit services to be provided by our independent auditors and establishing policies and procedures for the pre-approval of audit and non-audit services to be provided by the independent auditors;
|
|
•
|
meeting to review the audited and quarterly financial statements and discussing these statements with management and our independent auditors, including reviewing the Company’s specific disclosures under the “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the Company’s Annual Report on Form 10-K and based on such review and discussion, recommending to the Board as to the approval of the Company’s audited financial statements and if they should be included in the Company’s Annual Report on Form 10-K;
|
|
•
|
establishing procedures for the review, approval and ratification of related person transactions; and
|
|
•
|
reviewing and discussing the Company’s practices with respect to risk assessment and risk management and overseeing and evaluating the Company’s risk management policies in light of the Company’s business strategy, capital strength and overall risk tolerance.
|
|
•
|
identifying individuals qualified to become Board members (consistent with criteria recommended by the RNC and approved by the Board) and recommending to our Board nominees for election at the annual meeting of stockholders and nominees for each board committee;
|
|
•
|
reviewing and making recommendations to our Board concerning size, structure, composition and functioning of the Board and its committees;
|
|
•
|
discharging our Board’s responsibilities relating to the remuneration of our senior executives, including our Chief Executive Officer;
|
|
•
|
approving and evaluating our executive remuneration plans, policies and programs and ensuring that these plans, policies and programs enable us to attract and retain exceptional talents and incentivize them to achieve exceptional performance;
|
|
•
|
overseeing succession planning for our senior executives, including our Chief Executive Officer, and guiding our Board in appointing and retaining key talents that will nurture our values and culture and strive for constantly improving results;
|
|
•
|
recommending to our Board the corporate governance principles, annually reviewing them and recommending changes to the Board as appropriate;
|
|
•
|
reviewing and making recommendations with respect to the remuneration of all directors;
|
|
•
|
assessing the results of the Company’s most recent advisory vote on executive compensation;
|
|
•
|
reviewing and discussing with management the Company’s compensation discussion and analysis and SEC-required disclosures and recommending to the Board based on that review and discussion whether the compensation discussion and analysis should be included in the Company’s Annual Report on Form 10-K and/or proxy statement;
|
|
•
|
preparing the compensation committee report required by SEC rules to be included in the Company’s Annual Report on Form 10-K and/or proxy statement; and
|
|
•
|
overseeing the evaluation of the performance of our Board and management.
|
|
•
|
the director is, or has been within the last three years, our employee, or an immediate family member of the director is, or has been within the last three years, our executive officer;
|
|
•
|
the director has received, or has an immediate family member who has received, during any 12-month period during the last three years, more than $120,000 in direct compensation from us (other than Board and committee fees, and pension or other forms of deferred compensation for prior service). Compensation received by an immediate family member for service as our employee (other than an executive officer) is not considered for purposes of this standard;
|
|
•
|
(a) the director, or an immediate family member of the director, is a current partner of our internal or external auditor; (b) the director is a current employee of our internal or external auditor; (c) an immediate family member of the director is a current employee of our internal or external auditor who personally works on our audit; or (d) the director, or an immediate family member of the director, was within the last three years (but is no longer) a partner or employee of our internal or external auditor and personally worked on our audit within that time;
|
|
•
|
the director, or an immediate family member of the director, is, or has been within the last three years, employed as an executive officer of another company where any of our present executive officers serves or served at the same time on that company’s compensation committee;
|
|
•
|
the director is a current employee, or an immediate family member of the director is a current executive officer, of a company that has made payments to, or received payments from, us for property or services in an amount that, in any of the last three fiscal years, exceeds the greater of $1 million or 2% of the other company’s consolidated gross revenues; or
|
|
•
|
the director, or the director’s spouse, is an executive officer of a non-profit organization to which we make, or in the past three years have made, payments that, in any single fiscal year, exceeded the greater of $1 million or 2% of the non-profit organization’s consolidated gross revenues.
|
|
•
|
certain types of executive officer compensation;
|
|
•
|
compensation paid to a director if required to be reported under Item 402 of the SEC’s compensation disclosure requirements;
|
|
•
|
any transaction with another company to which a related person’s only relationship is as an employee (other than an executive officer) if the amount involved does not exceed the greater of $1 million or 2% of that company’s total annual revenue;
|
|
•
|
any charitable contribution, grant, or endowment by us to a charitable organization, foundation, or university to which a related person’s only relationship is as an employee (other than an executive officer) if the amount involved does not exceed the lesser of $1 million or 2% of the charitable organization’s total annual receipts;
|
|
•
|
any related person transaction where the related person’s interest arises solely from the ownership of our Common Stock and in which all stockholders receive proportional benefits; and
|
|
•
|
any related person transaction in which the rates or charges involved are determined by competitive bids.
|
|
Name
|
|
Age
|
|
Director Since
|
|
Lambertus J.H. Becht
|
|
60
|
|
2011
|
|
Joachim Faber
|
|
66
|
|
2010
|
|
Olivier Goudet
|
|
51
|
|
2013
|
|
Peter Harf
|
|
70
|
|
1996
|
|
Paul S. Michaels
|
|
64
|
|
2015
|
|
Camillo Pane
(1)
|
|
46
|
|
2016
|
|
Erhard Schoewel
|
|
67
|
|
2006
|
|
Robert Singer
|
|
64
|
|
2010
|
|
Name
(4)
|
|
Fees Earned or
Paid in Cash ($) (1) |
|
Stock
Awards ($) (2) |
|
Total
($)
|
|||||
|
Lambertus J.H. Becht
|
|
400,000
|
|
|
|
843,600
|
|
|
|
1,243,600
|
|
|
Joachim Faber
|
|
100,000
|
|
|
|
281,200
|
|
|
|
381,200
|
|
|
Olivier Goudet
|
|
100,000
|
|
|
|
281,200
|
|
|
|
381,200
|
|
|
Peter Harf
|
|
100,000
|
|
|
|
281,200
|
|
|
|
381,200
|
|
|
Paul S. Michaels
|
|
100,000
|
|
|
|
281,200
|
|
|
|
381,200
|
|
|
Erhard Schoewel
|
|
100,000
|
|
|
|
281,200
|
|
|
|
381,200
|
|
|
Robert Singer
|
|
130,000
|
|
|
|
281,200
|
|
|
|
411,200
|
|
|
Jack Stahl
(3)
|
|
100,000
|
|
|
|
244,222
|
|
|
|
344,222
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
The amount represents annual cash compensation for service as a director, Chairman or AFC Chair, as applicable. The amount does not include any compensation paid to Mr. Becht for his service as interim CEO, which compensation is reported under “Compensation Discussion and Analysis—Summary Compensation Table”.
|
||||||||||||||||
|
(2)
|
The amount represents the aggregate grant date fair value calculated in accordance with FASB ASC Topic 718 for restricted stock units issued to non-employee directors on November 15, 2015. See Note 23, “Share-Based Compensation Plans” in the notes to our Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended June 30, 2016 for certain assumptions used to calculate the valuation.
|
||||||||||||||||
|
(3)
|
Mr. Stahl resigned as a director of the Board on May 13, 2016. In accordance with the 2007 Director Plan, a pro rata portion of the 10,000 RSUs received by Mr. Stahl in fiscal 2016 vested, and the remaining 1315 RSUs he received in fiscal 2016 were forfeited.
|
||||||||||||||||
|
(4)
|
Presented below are the aggregate number of shares of Class A Common Stock underlying RSUs and stock options held by the directors as of June 30, 2016.
|
||||||||||||||||
|
Name
|
|
Total Number of Shares of Class A Common Stock Underlying RSUs Outstanding as of June 30, 2016
|
|
Total Number of Shares of Class A Common Stock Underlying Stock Options Outstanding as of June 30, 2016
|
|
Lambertus J.H. Becht
|
|
142,500
|
|
—
|
|
Joachim Faber
|
|
50,000
|
|
—
|
|
Olivier Goudet
|
|
31,666
|
|
—
|
|
Peter Harf
|
|
52,500
|
|
—
|
|
Paul S. Michaels
|
|
10,685
|
|
—
|
|
Erhard Schoewel
|
|
50,000
|
|
—
|
|
Robert Singer
|
|
50,000
|
|
—
|
|
Jack Stahl
(1)
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position(s) Held
|
|
Patrice de Talhouët
|
|
50
|
|
Chief Financial Officer
|
|
Sébastien Froidefond
|
|
48
|
|
Senior Vice President of Human Resources
|
|
Edgar Huber
|
|
54
|
|
President of Global Markets
|
|
Jules P. Kaufman
|
|
58
|
|
Senior Vice President, General Counsel and Secretary
|
|
Ralph Macchio
|
|
59
|
|
Senior Vice President of Global Research and Development, Chief Scientific Officer
|
|
Camillo Pane
|
|
46
|
|
Executive Vice President, Category Development
|
|
Mario Reis
|
|
57
|
|
Executive Vice President, Supply Chain
|
|
Kevin Monaco
|
|
52
|
|
Senior Vice President, Treasurer and Investor Relations
|
|
Ayesha Zafar
|
|
59
|
|
Senior Vice President, Group Controller
|
|
Common Stock Beneficially Owned
|
|||||||||||||||
|
Name of Beneficial Owner
|
|
Class A
(1)
|
|
Class B
|
|
% of Total
Voting Power
|
|||||||||
|
Shares
|
|
%
|
|
Shares
|
|
%
|
|
||||||||
|
Aristotle Capital Management LLC
|
|
4,497,668
|
|
(2)
|
6.1
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
FMR LLC
|
|
8,235,142
|
|
(3)
|
11.1
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
JAB Cosmetics B.V.
|
|
9,055,671
|
|
(4)
|
12.2
|
|
|
262,062,370
|
|
|
100
|
|
|
97.6
|
|
|
Mousseluxe S.á.r.l.
|
|
14,562,993
|
|
(5)
|
19.7
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Putnam Investments, LLC
|
|
9,426,900
|
|
(6)
|
12.7
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Vanguard Group
|
|
4,518,178
|
|
(7)
|
6.1
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Wellington Management Group LLP
|
|
7,599,442
|
|
(8)
|
10.3
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Lambertus J.H. Becht
|
|
4,668,810
|
|
(9)
|
6.3
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Patrice de Talhouët
|
|
207,297
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Joachim Faber
|
|
194,061
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Olivier Goudet
|
|
15,000
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Peter Harf
|
|
4,570,719
|
|
(10)
|
6.2
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Jules P. Kaufman
|
|
950,808
|
|
(11)
|
1.3
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Paul S. Michaels
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Jean Mortier
|
|
227,705
|
|
(12)
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Camillo Pane
|
|
215,307
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Mario Reis
|
|
136,000
|
|
(13)
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Erhard Schoewel
|
|
352,452
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Robert Singer
|
|
30,000
|
|
|
*
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
All Directors and Executive Officers as a Group (17 persons)
|
|
12,114,285
|
|
(14)
|
16.1
|
|
|
—
|
|
|
—
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Less than one percent
|
||||||||||||||||
|
(1)
|
Includes shares of Class A Common Stock subject to Stock Options that are currently exercisable or exercisable within 60 days of the Record Date, and RSUs, if any, that are vested but not settled or that will vest and are expected to settle within 60 days of the Record Date.
|
||||||||||||||||
|
(2)
|
Based solely on a Schedule 13G filed on July 29, 2016. Represents shares of Class A Common Stock beneficially owned by Aristotle Capital Management, LLC. Aristotle Capital Management, LLC has shared dispositive power over 4,497,668 shares and sole voting power over 2,540,173 shares. The address for Aristotle Capital Management, LLC is 11100 Santa Monica Blvd., Suite 1700, Los Angeles, California 90025.
|
||||||||||||||||
|
(3)
|
Based solely on a Schedule 13G filed on May 10, 2016. Represents shares of Class A Common Stock beneficially owned by FMR LLC and Abigail P. Johnson. Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR LLC. FMR LLC has sole voting power over 1,052,249 shares and FMR LLC and Abigail P. Johnson have sole dispositive power over 8,235,142 shares. The address for FMR LLC and Abigail P. Johnson is 245 Summer Street, Boston, Massachusetts 02210.
|
||||||||||||||||
|
(4)
|
Based solely on a Schedule 13G/A filed on February 16, 2016, Forms 4 filed on August 3, August 8, August 11, August 12, August 16, 2016, August 29, 2016 and August 31, 2016 and Forms 4/A filed on August 25, 2016 with respect to the Forms 4 filed on August 11, 2016, and August 16, 2016. Lucresca, Agnaten, each of which is a company with its registered seat in Austria, and JAB Holdings B.V., a Netherlands corporation, indirectly have voting and investment control over the shares held by JAB Cosmetics B.V., a Netherlands corporation. JAB Cosmetics B.V. is direct subsidiary of JAB Holdings B.V. and an indirect subsidiary of Agnaten and Lucresca. Lucresca and Agnaten are each controlled by Renate Reimann-Haas, Wolfgang Reimann, Stefan Reimann-Andersen and Matthias Reimann-Andersen, who with Peter Harf, Bart Becht and Olivier Goudet exercise voting and investment authority over the shares held by JAB Cosmetics B.V. Lucresca, Agnaten, and JAB Cosmetics B.V. disclaim the existence of a “group” and disclaim beneficial ownership of these securities except to the extent of a pecuniary interest therein. The address of Lucresca and Agnaten is Rooseveltplatz 4-5/Top 10, 1090 Vienna and the address of JAB Cosmetics B.V. and JAB Holdings B.V. is Oudeweg 147, 2031 CC Haarlem, The Netherlands.
|
||||||||||||||||
|
(5)
|
Based solely on a Form 4/A filed on December 8, 2015. Represents shares of Class A Common Stock beneficially owned by Mousseluxe S.à.r.l. These shares are indirectly owned by Charles Heilbronn, who has been granted a power of attorney and proxy to exercise voting and investment power with respect to these shares. Mousseluxe S.à.r.l. and Mr. Heilbronn have shared voting and dispositive power over these shares. The address for Mousseluxe S.à.r.l. is 65 Boulevard Grande Duchesse Charlotte, L-1331 Luxembourg. Address for Mr. Heilbronn is c/o Mousse Partners Limited, 9 West 57th Street, New York, NY 10019.
|
||||||||||||||||
|
(6)
|
Based solely on a Schedule 13G/A filed on February 16, 2016. Represents shares of Class A Common Stock beneficially owned by Putnam Investments, LLC (“Putnam”), which wholly owns two registered investment advisors: Putnam Investments Management, LLC (“PIM”), which is the investment advisor to the Putnam family of mutual funds and the Putnam Advisory Company, LLC (“PAC” together with Putnam and PIM, the “Putnam Group”), which is the investment advisor to Putnam’s institutional clients. Putnam has sole voting power over 1,134,598 shares and sole dispositive power over 9,426,900 shares, PIM has sole voting power over 326,718 shares and sole dispositive power over 8,619,020 shares, and PAC has sole voting and dispositive power over 807,880 shares. The address for the Putnam Group is One Post Office Square, Boston, MA 02109.
|
||||||||||||||||
|
(7)
|
Based solely on a Schedule 13G filed on February 10, 2016. Represents shares of Class A Common Stock beneficially owned by The Vanguard Group (“Vanguard Group”), which wholly owns Vanguard Fiduciary Trust Company (“Vanguard Fiduciary Trust”), an investment manager of collective trust accounts. Vanguard Group has sole voting power over 53,287 shares, sole dispositive power over 4,464,891 shares and shared dispositive power with Vanguard Fiduciary Trust over 53,287 shares. The address for The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.
|
||||||||||||||||
|
(8)
|
Based solely on a Schedule 13G filed on April 11, 2016. Represents shares of Class A Common Stock beneficially owned of record by clients of Wellington Management Company LLP, Wellington Management Canada LLC, Wellington Management Singapore Pte Ltd, Wellington Management Hong Kong Ltd, Wellington Management International Ltd, Wellington Management Japan Pte Ltd and Wellington Management Australia Pty Ltd (collectively, the “Wellington Investment Advisors”). Wellington Investment Advisors Holdings LLP controls directly, or indirectly through Wellington Management Global Holdings, Ltd., the Wellington Investment Advisors. Wellington Investment Advisors Holdings LLP is owned by Wellington Group Holdings LLP. Wellington Group Holdings LLP is owned by Wellington Management Group LLP. Each of Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP have shared voting power over 5,647,470 shares and shared dispositive power over 7,599,442 shares. Wellington Management Company LLP has shared voting power over 3,793,938 shares and shared dispositive power over 4,924,174 shares. The address of each of Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP is 280 Congress Street, Boston, Massachusetts 02210.
|
||||||||||||||||
|
(9)
|
Includes 3,668,810 shares of Class A Common Stock held by a Luxembourg corporation whose sole shareholder is a revocable trust that Mr. Becht established for estate planning purposes. While Mr. Becht does not have investment control over the trust or its assets, because Mr. Becht has the power to revoke the trust at any time and assume control of the Luxembourg corporation that owns such shares, pursuant to Rule 13d-3(a)(d)(1)(i)(C), Mr. Becht is deemed to be the beneficial owner of such shares for Section 13(d) purposes and has accordingly included them in the table set forth above.
|
||||||||||||||||
|
(10)
|
3,920,719 shares of Class A Common Stock are pledged to secure a loan under a loan facility with a bank.
|
||||||||||||||||
|
(11)
|
Includes 532,630 shares of Class A Common Stock issuable upon exercise of vested options and 190,000 stock options vesting within 60 days of the Record Date.
|
||||||||||||||||
|
(12)
|
Mr. Mortier is the Company’s former President of Global Markets. Based solely on his ownership as of June 30, 2016, his termination date.
|
||||||||||||||||
|
(13)
|
110,000 shares of Class A Common Stock are pledged to secure a loan under a loan facility with a bank.
|
||||||||||||||||
|
(14)
|
Includes 644,630 shares of Class A Common Stock issuable upon exercise of vested options and 530,000 shares of Class A Common Stock issuable within 60 days of the Record Date.
|
||||||||||||||||
|
|
Avon Products, Inc.
|
|
Kimberly Clark Corporation
|
|
|
|
The Clorox Company
|
|
L’Oreal
|
|
|
|
Colgate-Palmolive Company
|
|
The Procter and Gamble Company
|
|
|
|
Elizabeth Arden, Inc.
|
|
Revlon, Inc.
|
|
|
|
The Estée Lauder Company, Inc.
|
|
Unilever PLC
|
|
|
|
Inter Parfums, Inc.
|
|
|
|
|
Performance Levels
|
|
Profit
|
|
Net Revenues
|
|
Net Working
Capital
|
|
% of Target
Award
|
|
Significantly Exceeds Target
|
|
167%
|
|
167%
|
|
129%
|
|
360%
|
|
Exceeds Target
|
|
134%
|
|
134%
|
|
115%
|
|
206%
|
|
Target
|
|
100%
|
|
100%
|
|
100%
|
|
100%
|
|
Below Target
|
|
65%
|
|
85%
|
|
90%
|
|
50%
|
|
Significantly Below Target
|
|
35%
|
|
70%
|
|
80%
|
|
20%
|
|
Minimum (Killer Factor)
|
|
0%
|
|
55%
|
|
70%
|
|
0%
|
|
Bonus Percentage Calculation:
|
|
1.67 x 1.34 x 1.15
|
|
=
|
|
2.5735
|
|
Overall APP Factor:
|
|
257%
|
|
|
|
|
|
Final APP Award:
|
|
2.57 x 0.5 x $500,000
|
|
=
|
|
$642,500
|
|
Total Cash Compensation:
|
|
$500,000 + $642,500
|
|
=
|
|
$1,142,500
|
|
Name & Title
|
|
Year
|
|
Salary ($)
(1)
|
|
Stock
Awards
($)
(2)
|
|
Option
Awards
($)
(3)
|
|
Non-Equity
Incentive
Plan
Compensation
($)
(1)(4)
|
|
All Other
Compensation
($)
(1)
|
|
Total
Compensation
($)
(1)
|
|||||||||
|
Lambertus J.H. Becht, Interim CEO
|
|
2016
|
|
|
|
8,106,000
|
|
(5)
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
8,106,000
|
|
|
|
|
|
2015
|
|
—
|
|
|
1,000,009
|
|
(5)
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
1,000,009
|
|
|
Patrice de Talhouët, CFO
|
|
2016
|
|
784,100
|
|
|
1,500,007
|
|
|
|
—
|
|
|
551,800
|
|
|
|
132,512
|
|
(6)
|
|
2,968,419
|
|
|
|
|
2015
|
|
765,000
|
|
|
1,418,842
|
|
|
|
3,257,357
|
|
|
711,800
|
|
|
|
256,923
|
|
(6)
|
|
6,409,922
|
|
|
|
|
2014
|
|
375,000
|
|
|
1,137,485
|
|
|
|
—
|
|
|
195,075
|
|
|
|
220,108
|
|
(6)
|
|
1,927,668
|
|
|
Jean Mortier, Former President of Global Markets
|
|
2016
|
|
663,480
|
|
|
1,999,999
|
|
|
|
—
|
|
|
587,180
|
|
|
|
9,080,341
|
|
(7)
|
|
12,331,000
|
|
|
|
|
2015
|
|
719,995
|
|
|
1,986,000
|
|
|
|
5,439,289
|
|
|
793,631
|
|
|
|
15,335
|
|
(7)
|
|
8,954,250
|
|
|
|
|
2014
|
|
719,210
|
|
|
1,945,200
|
|
|
|
—
|
|
|
400,456
|
|
|
|
17,399
|
|
(7)
|
|
3,082,265
|
|
|
Camillo Pane, EVP, Category Development
|
|
2016
|
|
592,320
|
|
|
2,876,000
|
|
|
|
—
|
|
|
711,376
|
|
(8)
|
|
115,673
|
|
(9)
|
|
4,295,369
|
|
|
Mario Reis, EVP, Supply Chain
|
|
2016
|
|
609,560
|
|
|
1,000,014
|
|
|
|
—
|
|
|
429,919
|
|
|
|
25,573
|
|
(10)
|
|
2,065,066
|
|
|
|
|
2015
|
|
609,997
|
|
|
993,000
|
|
|
|
3,257,357
|
|
|
617,030
|
|
|
|
41,633
|
|
(10)
|
|
5,519,017
|
|
|
Jules P. Kaufman, SVP, General Counsel & Secretary
|
|
2016
|
|
525,000
|
|
|
750,003
|
|
|
|
—
|
|
|
366,000
|
|
|
|
18,365
|
|
(11)
|
|
1,659,368
|
|
|
|
|
2015
|
|
492,700
|
|
|
744,750
|
|
|
|
3,263,575
|
|
|
441,500
|
|
|
|
11,278
|
|
(11)
|
|
4,953,803
|
|
|
|
|
|
(1)
|
Mr. Mortier is paid in Euros. Mr. de Talhouët and Mr. Kaufman are paid in U.S. dollars. Mr. Reis is paid in Swiss Francs. Mr. Pane is paid in British pounds. Exchange rates for fiscal 2016 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
(2)
|
Amounts represent the grant date fair value of the RSUs granted on January 1, 2014, February 18, 2014, September 30, 2014 and September 30, 2015 and matching Platinum RSUs granted on February 21, 2014, November 7, 2014 as well as RSUs granted on July 21, 2015 and September 21, 2015, in each case calculated in accordance with FASB ASC Topic 718.
|
||||||||||||||||
|
(3)
|
Amounts represent the grant date fair value of Options and Series A Preferred Stock granted on April 15, 2015 under the ELTIP, in each case calculated in accordance with FASB ASC Topic 718. Options and Series A Preferred Stock were issued, in each case, pursuant to the executive’s ownership of a minimum level of Class A Common Stock.
|
||||||||||||||||
|
(4)
|
Amounts represent cash awards paid under the APP in October 2014 with respect to fiscal 2014 performance, in October 2015 with respect to fiscal 2015 performance and expected to be paid in October 2016 with respect to fiscal 2016 performance.
|
||||||||||||||||
|
(5)
|
In fiscal 2015 Mr. Becht received an award of phantom units granted on December 1, 2014, valued at $1,000,009 based on the closing price of Class A Common Stock on December 1, 2014. In fiscal 2016 Mr. Becht received an award of phantom units granted on July 21, 2015, valued at $8,106,000 based on the closing price of Class A Common Stock on July 21, 2015. These awards were granted outside of any equity compensation plans of the Company.
|
||||||||||||||||
|
(6)
|
In fiscal 2014, we provided Mr. de Talhouët with a car lease valued at $6,487, reimbursement for travel to France valued at $25,988, reimbursement for his children’s school tuition valued at $107,283, plus tax gross ups for such education valued at $69,827. Additionally, in 2014, Mr. de Talhouët received assistance in and reimbursement for the cost of renewing his work permit and visas valued at $10,523. In fiscal 2015, we provided Mr. de Talhouët with a car allowance valued at $4,898 paid in one installment in December 2014, a Company car lease valued at $8,470 for fiscal 2015, reimbursement for travel to France valued at $13,923, reimbursement for children’s school tuition in the amount of $118,555, plus tax gross ups for such education valued at $97,172, and reimbursement for tax assistance in amount of $11,972. Mr. de Talhouët also received a discount of $1,933 on shares purchased on April 15, 2015 from JAB Cosmetics B.V., based on the difference between the purchase price of $24.86 per share and the market closing price of $24.97. In fiscal 2016, we provided Mr. de Talhouët with a car allowance valued at $7,054 paid in one installment in December 2015, a Company car lease valued at $8,381 for fiscal 2016, reimbursement for travel to France valued at $20,626, reimbursement for children’s school tuition in the amount of $58,110, plus gross up taxes for such education valued at $38,341.
|
||||||||||||||||
|
(7)
|
Mr. Mortier served as President of Global Markets and a member of the Coty Executive Committee until his succession by Mr. Huber in November 2015. We provided Mr. Mortier with a car lease valued at $17,399 in fiscal 2014, $15,335 in fiscal 2015 and $18,339 in fiscal 2016 for a dual-purpose Company car. In addition, pursuant to the Separation Agreement (as defined below), Mr. Mortier received a global settlement payment of approximately $5,409,400; a severance payment of approximately $2,331,200; reimbursement for paid leave not taken of approximately $170,983; reimbursement for costs associated with legal and advisor fees of approximately $4,976; and an exceptional bonus in the amount of $1,145,443.
|
||||||||||||||||
|
(8)
|
Mr. Pane received a one-time cash payment in the amount of $222,220 to alleviate the lost bonus opportunity with his former employer. Mr. Pane would have been required to repay this amount to the Company in the event of Mr. Pane’s resignation or termination for cause within 12 months from Mr. Pane’s date of hire.
|
||||||||||||||||
|
(9)
|
We provided Mr. Pane with the car allowance in the amount of $19,547 and reimbursement for his children’s school tuition valued at $51,079, plus gross up taxes for such education valued at $45,047.
|
||||||||||||||||
|
(10)
|
In fiscal 2015, we provided Mr. Reis with a car allowance in the amount of $7,735 for the period of July 2014 through September 2014 and dual-purpose Company car valued at $24,798 for the period of October 2014 through June 2015. Mr. Reis received a discount of $9,100 on shares purchased on June 12, 2015 from JAB Cosmetics B.V., based on the difference between the purchase price of $25.92 and the market closing price of $26.27. In fiscal 2016, we provided Mr. Reis with a car lease valued at $25,573.
|
||||||||||||||||
|
(11)
|
We provided Mr. Kaufman with a car allowance and car lease in the aggregate amount of $11,278 in fiscal 2015 and $18,365 in fiscal 2016.
|
||||||||||||||||
|
Name
|
|
Grant
Date
|
|
Estimated Future Payments
under Non-Equity Incentive
Plan Awards ($)
(1)
|
|
All Other
Stock Awards:
Number of
Shares of
Stock or
Units (#)
(2)
|
|
Grant Date
Fair
Value of
Stock and
Option
Awards ($)
|
|||||||||||||
|
Minimum
|
|
Target
|
|
Maximum
|
|
||||||||||||||||
|
Lambertus J.H. Becht
|
|
7/21/2015
|
|
—
|
|
|
—
|
|
|
—
|
|
|
300,000
|
|
|
|
|
8,106,000
|
|
|
|
|
Patrice de Talhouët
|
|
9/21/2015
|
|
|
|
|
|
|
|
52,156
|
|
|
|
|
1,500,007
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
470,460
|
|
|
1,693,656
|
|
|
|
|
|
|
|
|
|
||
|
Jean Mortier
|
|
9/21/2015
|
|
|
|
|
|
|
|
69,541
|
|
|
|
|
1,999,999
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
497,610
|
|
|
1,791,396
|
|
|
|
|
|
|
|
|
|
||
|
Camillo Pane
|
|
9/21/2015
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
2,876,000
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
414,624
|
|
|
1,492,646
|
|
|
|
|
|
|
|
|
|
||
|
Mario Reis
|
|
9/21/2015
|
|
|
|
|
|
|
|
34,771
|
|
|
|
|
1,000,014
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
365,736
|
|
|
1,316,651
|
|
|
|
|
|
|
|
|
|
||
|
Jules P. Kaufman
|
|
9/21/2015
|
|
|
|
|
|
|
|
26,078
|
|
|
|
|
750,003
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
315,000
|
|
|
1,134,000
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
(1)
|
Represents the range of possible payments under the APP based on each NEO’s annual base salary at fiscal year-end. Mr. Mortier will be paid in Euros, and Mr. Reis will be paid in Swiss Francs. Mr. Pane will be paid in British pounds. Exchange rates for fiscal 2016 compensation are calculated using the weighted average monthly exchange rate during the fiscal year. Awards under the APP are expected to be paid in October 2016.
|
||||||||||||||||
|
(2)
|
Represents the annual long-term incentive compensation award of Restricted Stock Units under the ELTIP. Also represents phantom units not granted pursuant to any equity compensation plan of the Company.
|
||||||||||||||||
|
|
Target
|
|
Minimum
|
|
Significantly Below
|
|
Below
|
|
Target
|
|
Exceeds
|
|
Significantly Exceeds
|
|
Actual
|
||||||||||||||||||||||||||||
|
|
Improve-ment
over
prior year
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
|
Delta
(bps)
with
Target
|
|
Payout
(Factor)
|
||||||||||||||
|
Net Income Attributable to Coty Inc. Growth YOY (40%)
|
14
|
%
|
|
<(1,200)
|
|
—
|
|
|
(1,200
|
)
|
|
0.35
|
|
|
(600
|
)
|
|
0.65
|
|
|
—
|
|
|
1
|
|
|
300
|
|
|
1.34
|
|
|
600
|
|
|
1.67
|
|
|
1,059
|
|
|
1.67
|
|
|
Net Revenues Growth YOY (40%)
|
5.2 %
|
|
|
<(160)
|
|
0.55
|
|
|
(160
|
)
|
|
0.7
|
|
|
(80
|
)
|
|
0.85
|
|
|
—
|
|
|
1
|
|
|
60
|
|
|
1.34
|
|
|
120
|
|
|
1.67
|
|
|
(289
|
)
|
|
0.55
|
|
|
Average NWC as % of Rolling Sales Improvement YOY in basis point (20%)
|
100
|
|
|
<(100)
|
|
0.7
|
|
|
(100
|
)
|
|
0.8
|
|
|
(50
|
)
|
|
0.9
|
|
|
—
|
|
|
1
|
|
|
20
|
|
|
1.15
|
|
|
40
|
|
|
1.29
|
|
|
277
|
|
|
1.29
|
|
|
TOTAL
|
|
|
|
|
|
0
|
|
|
|
|
|
0.2
|
|
|
|
|
|
0.5
|
|
|
|
|
|
1
|
|
|
|
|
|
2.06
|
|
|
|
|
|
3.60
|
|
|
|
|
|
1.18
|
|
|
Name
|
|
|
Salary ($)
(1)
|
|
Award
Target
Relative to
Salary (%)
|
|
Award
Minimum ($)
|
|
Award
Maximum ($)
|
|
Award
Target ($)
|
|
Actual
APP
Factor
|
|
Actual
Award ($)
(2)
|
|||||||
|
Lambertus J.H. Becht
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Patrice de Talhouët
|
|
|
784,100
|
|
|
60%
|
|
—
|
|
|
1,693,656
|
|
|
470,460
|
|
|
1.18
|
|
|
551,800
|
|
|
|
Jean Mortier
|
|
|
663,480
|
|
|
75%
|
|
—
|
|
|
1,791,396
|
|
|
497,610
|
|
|
1.18
|
|
|
587,180
|
|
|
|
Camillo Pane
|
|
|
592,320
|
|
|
70%
|
|
—
|
|
|
1,492,646
|
|
|
414,624
|
|
|
1.18
|
|
|
489,256
|
|
|
|
Mario Reis
|
|
|
609,560
|
|
|
60%
|
|
—
|
|
|
1,316,651
|
|
|
365,736
|
|
|
1.18
|
|
|
429,919
|
|
|
|
Jules P. Kaufman
|
|
|
525,000
|
|
|
60%
|
|
—
|
|
|
1,134,000
|
|
|
315,000
|
|
|
1.18
|
|
|
366,000
|
|
|
|
|
|
|
(1)
|
|
Represents annual base salary as of June 30, 2016. In fiscal 2016 Mr. Mortier was paid in Euros and Mr. Reis was paid in Swiss Francs. Mr. Pane was paid in British pounds. Exchange rates for fiscal 2016 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
(2)
|
|
Actual award amounts are calculated based on each NEO’s annual base salary in the local currency in which they are paid. Exchange rates for fiscal 2016 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
NEO
|
|
Option Awards
|
|
Stock Awards
|
||||||||||||||||
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
(1)
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
(1)
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Number of
Shares or
Units of
Stock
That Have
Not
Vested (#)
|
|
Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested ($)
|
||||||||||
|
Lambertus J.H. Becht
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
(2)
|
|
|
7,797,000
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
49,432
|
|
(2)
|
|
|
1,284,738
|
|
|||
|
Patrice de Talhouët
|
|
|
|
621,633
|
|
(3)
|
|
27.97
|
|
|
4/15/2025
|
|
52,156
|
|
(4)
|
|
|
1,355,534
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
(5)
|
|
|
1,559,400
|
|
|||
|
Camillo Pane
|
|
|
|
645,921
|
|
(3)
|
|
27.97
|
|
|
4/15/2025
|
|
100,000
|
|
(4)
|
|
|
2,599,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Mario Reis
|
|
|
|
408,000
|
|
(3)
|
|
27.97
|
|
|
4/15/2025
|
|
34,771
|
|
(4)
|
|
|
903,698
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
(5)
|
|
|
1,559,400
|
|
|||
|
Jules P. Kaufman
|
|
|
|
372,980
|
|
|
|
24.13
|
|
|
4/15/2025
|
|
26,078
|
|
(4)
|
|
|
677,767
|
|
|
|
|
|
|
|
230,600
|
|
|
|
10.5
|
|
|
1/10/2022
|
|
45,000
|
|
(5)
|
|
|
1,169,550
|
|
|
|
|
|
|
|
190,000
|
|
|
|
10.5
|
|
|
9/22/2021
|
|
45,000
|
|
(6)
|
|
|
1,169,550
|
|
|
|
|
|
212,630
|
|
|
|
|
|
9.2
|
|
|
12/3/2020
|
|
1,092
|
|
(7)
|
|
|
28,381
|
|
|
|
|
|
170,000
|
|
|
|
|
|
9.2
|
|
|
9/14/2020
|
|
37,500
|
|
(8)
|
|
|
974,625
|
|
|
|
|
|
75,000
|
|
|
|
|
|
8.25
|
|
|
9/8/2019
|
|
|
|
|
|
|
|||
|
|
|
75,000
|
|
|
|
|
|
6.4
|
|
|
1/7/2019
|
|
|
|
|
|
|
|||
|
|
|
|
(1)
|
Each of the Stock Options, matching options under the EOP (“Matching Options”) and Options described in this table expires ten years after the grant date. All Stock Options, Matching Options and Options vest on the fifth anniversary of the grant date, subject to certain vesting conditions. All Series A Preferred Stock described in this table expire after seven years and vest on the fifth anniversary of the grant date, subject to certain vesting conditions.
|
|
(2)
|
Represents phantom units granted on December 1, 2014 and July 21, 2015. The phantom units vest on the fifth anniversary of the grant date, subject to certain vesting conditions. Mr. Becht also received RSUs granted under the 2007 Director Plan in connection with his services as Chairman of the Board. The grants of 30,000, 30,000, 30,000, 30,000 and 22,500 RSUs were granted in November 2015, 2014, 2013, 2012 and 2011, respectively, and vest five years after the grant date.
|
|
(3)
|
Represents Series A Preferred Stock granted under the ELTIP on April 15, 2015 that vest five years after the grant date, subject to certain vesting conditions.
|
|
(4)
|
Represents RSUs granted under the ELTIP on September 21, 2015 that vest five years after the grant date.
|
|
(5)
|
Represents RSUs granted under the ELTIP on September 30, 2014 that vest five years after the grant date.
|
|
(6)
|
Represents RSUs granted under the ELTIP on September 30, 2013 that vest five years after the grant date.
|
|
(7)
|
Represents matching Platinum RSUs granted on January 17, 2013 in connection with purchase of stock under Platinum.
|
|
(8)
|
Represents RSUs granted under the LTIP on September 25, 2012 that vest five years after the grant date.
|
|
NEO
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||
|
Number of
shares
acquired on
exercise (#)
|
|
Value
realized on
exercise ($)
(1)
|
|
Number of
shares
acquired on
vesting (#)
|
|
|
Value
realized on
vesting ($)
|
|
|||||||
|
Lambertus J.H. Becht
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Patrice de Talhouët
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Jean Mortier
|
|
26,276
|
|
(2)
|
|
493,997
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
73,724
|
|
(2)
|
|
1,397,107
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
99,700
|
|
(2)
|
|
1,755,877
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
100,000
|
|
(2)
|
|
1,895,050
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
82,521
|
|
(2)
|
|
1,783,188
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
3,174
|
|
(2)
|
|
65,384
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
2,200
|
|
(2)
|
|
45,360
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
12,105
|
|
(2)
|
|
249,852
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
24,091
|
|
(2)
|
|
452,680
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
30,909
|
|
(2)
|
|
596,896
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
70,000
|
|
(2)
|
|
1,222,753
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
45,000
|
|
(2)
|
|
826,263
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
74,980
|
|
(2)
|
|
1,309,743
|
|
|
—
|
|
|
|
—
|
|
|
|
Camillo Pane
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Mario Reis
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Jules P. Kaufman
|
|
110,250
|
|
(3)
|
|
2,193,600
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Represents the difference between the closing price of the Class A Common Stock on the exercise date and the exercise price multiplied by the number of shares underlying each option exercised.
|
||||||||||||||||
|
(2)
|
26,276 options exercised were granted on September 10, 2007 at an exercise price of $10.20; 73,724 options exercised were granted on September 10, 2007 at an exercise price of $10.20; 99,700 options exercised were granted on November 1, 2007 at an exercise price of $10.20; 100,000 options exercised were granted on November 1, 2007 at an exercise price of $10.20; 82,521 options exercised were granted on January 7, 2009 at an exercise price of $6.40; 3,174 options exercised were granted on January 7, 2009 at an exercise price of $6.40; 2,200 options exercised were granted on January 7, 2009 at an exercise price of $6.40; 12,105 options exercised were granted on January 7, 2009 at an exercise price of $6.40; 24,091 options exercised were granted on September 8, 2009 at an exercise price of $8.25; 30,909 options exercised were granted on September 8, 2009 at an exercise price of $8.25; 70,000 options exercised were granted on September 14, 2010 at an exercise price of $9.20; 45,000 options exercised were granted on September 14, 2010 at an exercise price of $9.20; 74,980 options exercised were granted on December 3, 2010 at an exercise price of $9.20;
|
||||||||||||||||
|
(3)
|
110,250 options exercised were granted on March 2, 2009 at an exercise price of $6.40
|
||||||||||||||||
|
•
|
Mr. de Talhouët is entitled to 90-days base salary if his employment is terminated due to resignation or retirement and 12 months base salary if his employment is terminated without cause.
|
|
•
|
Mr. Pane is entitled to 6 months base salary if his employment is terminated without cause.
|
|
•
|
Mr. Reis is entitled to 12 months base salary if his employment is terminated without cause.
|
|
•
|
Mr. Kaufman is entitled to 12 months base salary if his employment is terminated without cause or due to resignation with good reason, base salary for 13 weeks (minus any sums granted under statutory sick pay or
|
|
Name
|
|
Resignation
with Good
Reason
|
|
Termination
without
cause
|
|
Termination
for cause
|
|
Resignation
without
Good Reason
|
|
Disability,
Retirement
or death
|
|
Change in
Control
(1)
|
|
Resignation
with Good
Reason or
Termination
without
Cause after
Change in
Control
(2)
|
|||||||||
|
Lambertus J.H. Becht
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,081,738
|
|
|
|
9,081,738
|
|
|
9,081,738
|
|
|
|
Patrice de Talhouët
|
|
193,340
|
|
|
784,100
|
|
|
—
|
|
|
193,340
|
|
|
1,308,005
|
|
(3)
|
|
940,920
|
|
|
3,108,274
|
|
(4)
|
|
Camillo Pane
|
|
—
|
|
(5)
|
296,160
|
|
|
—
|
|
(5)
|
—
|
|
(5)
|
892,283
|
|
(5)
|
|
829,248
|
|
|
2,599,000
|
|
(6)
|
|
Mario Reis
|
|
—
|
|
|
609,560
|
|
|
—
|
|
|
—
|
|
|
1,116,055
|
|
|
|
731,473
|
|
|
2,463,098
|
|
(7)
|
|
Jules P. Kaufman
|
|
525,000
|
|
|
525,000
|
|
|
—
|
|
|
—
|
|
|
8,452,470
|
|
(8)
|
|
9,854,108
|
|
|
11,753,710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Includes accelerated vesting of stock options granted before March 2011, the date we amended our LTIP and EOP to require a “double-trigger” for accelerated vesting in connection with a change in control of the Company.
|
|
(2)
|
Incremental payments represented in this column do not include any incremental payments reported in the column labeled “Change in Control” that the NEO is entitled to receive pursuant to such change in control.
|
|
(3)
|
Represents incremental payments Mr. de Talhouët is entitled to receive upon termination of his employment due to his disability or death. Mr. de Talhouët is entitled to receive an additional $193,340 upon his retirement.
|
|
(4)
|
Represents incremental payments Mr. de Talhouët is entitled to receive if he had resigned for good reason after a change in control. Mr. de Talhouët is entitled to receive an additional $590,760 if his employment had been terminated without cause after a change in control.
|
|
(5)
|
Mr. Pane received a one-time cash payment in the amount of $222,220 to alleviate the lost bonus opportunity with his former employer. Mr. Pane is required to repay this amount to the Company in the event of Mr. Pane’s resignation or termination for cause within 12 months from Mr. Pane’s date of hire.
|
|
(6)
|
Represents incremental payments Mr. Pane is entitled to receive if he had been terminated without cause after a change in control. Mr. Pane would fully repay a cash bonus of $222,220 if he resigned with good reason after a change in control.
|
|
(7)
|
Represents incremental payments Mr. Reis is entitled to receive if he had resigned for good reason after a change in control. Mr. Reis is entitled to receive an additional $609,997 if his employment had been terminated without cause after a change in control.
|
|
(8)
|
Represents incremental payments Mr. Kaufman is entitled to receive upon termination of his employment due to his retirement. Mr. Kaufman is entitled to receive an additional $43,750 upon termination due to death and an additional $131,250 upon termination due to disability.
|
|
•
|
the individuals eligible to receive compensation (see “—Summary of the ELTIP—Eligibility” below);
|
|
•
|
a description of the business criteria on which the performance goals are based (see “—Summary of the ELTIP—Performance Criteria” below); and
|
|
•
|
either the maximum amount of compensation that could be paid to an employee if the performance goals are attained or the formula used to calculate the amount of compensation to be paid to the employee if the performance goals are attained (see “—Summary of the ELTIP—Individual Limits” below).
|
|
Fiscal Year
|
|
|
RSUs
Granted
|
|
|
Common Shares
Outstanding
|
|
Burn Rate
|
|||
|
2014
|
|
|
1,779,325
|
|
|
|
383,917,514
|
|
|
0.46
|
|
|
2015
|
|
|
1,792,580
|
|
|
|
389,026,899
|
|
|
0.46
|
|
|
2016
|
|
|
1,293,627
|
|
|
|
360,862,168
|
|
|
0.36
|
|
|
•
|
select eligible employees to participate in the ELTIP;
|
|
•
|
determine the size and type of awards;
|
|
•
|
determine the terms and conditions of awards in a manner consistent with the ELTIP;
|
|
•
|
determine whether, to what extent, and under what circumstances awards may be settled or exercised in Class A Common Stock, and the method by which awards may be settled or exercised;
|
|
•
|
determine the fair market value of the Class A Common Stock;
|
|
•
|
construe and interpret the ELTIP and any agreement or instrument entered into under the ELTIP;
|
|
•
|
establish, amend or waive rules and regulations for the ELTIP’s administration;
|
|
•
|
specify the exercise price in connection with an award of a stock option or stock appreciation right;
|
|
•
|
amend the terms and conditions of any outstanding award to the extent the amended terms are within the committee’s authority under the ELTIP; and
|
|
•
|
make all other determinations that may be necessary or advisable to administer the ELTIP.
|
|
•
|
Stock options
. A stock option is a contractual right to purchase shares at a future date at a specified exercise price. The per share exercise price of a stock option will be determined by the committee and may not be less than the closing price of a share on the grant date. The committee will determine the date after which each stock option may be exercised and the expiration date of each option.
|
|
•
|
Stock appreciation rights
. SARs represent a contractual right to receive, in cash or shares, an amount equal to the appreciation of one share from the grant date. Any SAR will be granted subject to the same terms and conditions as apply to stock options.
|
|
•
|
Restricted shares
. Restricted shares are an award of shares that are subject to restrictions on transfer and a substantial risk of forfeiture.
|
|
•
|
Restricted stock units
. Restricted stock units represent a contractual right to receive a share (or cash in an amount equal to the value of a share) at a future date, subject to specified vesting and other restrictions.
|
|
•
|
Performance awards
. Performance awards, which may be denominated in cash or shares, will be earned on the satisfaction of performance criteria specified by the committee. The committee has authority to specify that any other award granted under the ELTIP will constitute a performance award by conditioning the exercisability or settlement of the award on the satisfaction of performance criteria.
|
|
•
|
Other stock-based awards
. The committee is authorized to grant other stock-based awards, which may be denominated in shares or denominated or payable in, valued by reference to, or otherwise based on or related to shares, including securities convertible into shares.
|
|
Plan Category
|
|
|
|
|
|
|
||||
|
(1)
Number of securities
to be issued upon
exercise of outstanding
options, warrants
and rights
|
|
(2)
Weighted-average
exercise price
of outstanding
options, warrants
and rights
|
|
(3)
Number of securities
remaining available
for future issuance
under equity
compensation plans
(d
)
(excluding securities
(e
)
reflected in column(1))
|
||||||
|
Equity compensation plans approved by security holders
|
|
|
|
|
|
|
||||
|
Options
|
|
6,420,295
|
|
|
$
|
11.41
|
|
|
|
|
|
Series A Preferred Stock
|
|
1,029,633
|
|
|
27.97
|
|
|
|
||
|
Restricted Stock Units
|
|
4,219,465
|
|
|
n/a
|
|
|
|
||
|
Subtotal
|
|
11,669,393
|
|
|
—
|
|
|
13,123,294
|
|
|
|
Equity compensation plans not approved by security holders
|
|
|
|
|
|
|
||||
|
Options
(a)
|
|
819,038
|
|
|
$
|
9.98
|
|
|
—
|
|
|
Series A Preferred Stock
(b)
|
|
645,921
|
|
|
27.97
|
|
|
|
||
|
Phantom Units
(c)
|
|
349,432
|
|
|
n/a
|
|
|
|
||
|
Subtotal
|
|
1,814,391
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
13,483,784
|
|
|
|
|
13,123,294
|
|
||
|
|
|
|
Fee Type
|
|
Fiscal 2016
(in thousands) |
|
Fiscal 2015
(in thousands) (5) |
||||
|
Audit Fees
(1)
|
|
$
|
8,125
|
|
|
$
|
7,308
|
|
|
Audit-Related Fees
(2)
|
|
532
|
|
|
236
|
|
||
|
Tax Fees
(3)
|
|
5,787
|
|
|
1,967
|
|
||
|
All Other Fees
(4)
|
|
167
|
|
|
141
|
|
||
|
Total
|
|
$
|
14,611
|
|
|
$
|
9,653
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
This category represents the fees associated with the annual audit, the audit of internal control over financial reporting, international statutory audit requirements and regulatory filings.
|
|
(2)
|
This category includes fees paid for professional services associated with agreed upon procedures for one of our licenses for fiscal 2015, due diligence support, and support related to audit readiness for the Transactions.
|
|
(3)
|
This category represents the fees for tax-related services, including tax compliance, tax advice, and tax planning. In fiscal 2016, we incurred $4,000,000 related to tax advice and tax planning for the Transactions.
|
|
(4)
|
This category represents all other fees that are not included in the above categories, and represents primarily fees paid for benchmarking and the provision of other data related to management compensation arrangements.
|
|
(5)
|
Fiscal 2015 was updated to include additional invoices related to fiscal 2015 audit fees of $644,000 and audit related fees of $60,000. Additionally, fiscal 2015 was updated to exclude additional invoices for fiscal 2014 for audit fees of $376,000 and audit related fees of $60,000.
|
|
1.
|
Reviewed and discussed the Company’s audited financial statements for the fiscal year ended June 30, 2016 with management;
|
|
2.
|
Discussed with Deloitte & Touche LLP the matters required to be discussed under Public Company Accounting Oversight Board standards; and
|
|
3.
|
Received the written disclosures and the letter from Deloitte & Touche LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding Deloitte & Touche LLP’s communications with the AFC concerning independence and has discussed with Deloitte & Touche LLP their independence from management and the Company.
|
|
|
|
By order of the Board of Directors,
|
|
|
|
|
|
|
|
|
|
|
|
Jules P. Kaufman
|
|
|
|
|
|
Senior Vice President, General Counsel and Secretary
|
||
|
1.1
|
Purpose
. The purpose of this Coty Inc. Equity and Long-Term Incentive Plan is to promote the interests of Coty Inc. and its shareholders by (i) attracting and retaining exceptional executive personnel and other key employees of the Company and its Affiliates; (ii) motivating such employees by means of performance-related incentives to achieve long-range performance goals; and (iii) enabling such employees to participate in the long-term growth and financial success of the Company.
|
|
(a)
|
The original effective date of the Plan is November 8, 2012. This Plan was first amended and restated on April 8, 2013, amended and restated again on October 28, 2015 and again on [ ], 2016. The effective date of this second amended and restated plan document is the Third Restatement Effective Date.
|
|
(b)
|
The Plan will terminate upon the earlier of (i) the date on which all Shares available for issuance under the Plan have been issued pursuant to the exercise of Stock Options or the Award of Shares under the Plan, or (ii) the date specified by action of the Board. Upon such Plan termination, all Awards outstanding under the Plan will continue to have full force and effect in accordance with the terms of the Terms and Conditions evidencing each Award.
|
|
2.1
|
“Affiliate” means any entity (i) that, directly or indirectly, is controlled by the Company, or in which the Company has a significant equity interest, and (ii) as to which the Company is an “eligible issuer of service recipient stock” within the meaning of Treas. Reg. 1.409A-1(b)(5)(iii)(E), in any such case as determined by the Committee.
|
|
2.2
|
“Applicable Fraction” means a fraction, the numerator of which is the number of days elapsed from the Grant Date of an Award to the date of the Participant’s termination of Service and the denominator of which is the number of days between the Grant Date and the date the Award was scheduled to become exercisable or otherwise vest.
|
|
2.3
|
“Award” means a grant under the Plan to a Participant of a Stock Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Performance Award, or Other Stock-Based Award.
|
|
2.4
|
“Board” means the Board of Directors of the Company.
|
|
2.5
|
“Business Day” means any day other than a Saturday, Sunday, or legal holiday, or a day on which the national securities exchange that constitutes the principal market for the Shares is closed.
|
|
2.6
|
“Cause” has the meaning set forth in any employment, severance or other agreement between the Company or an Affiliate and the Participant. If there is no employment, severance or other agreement between the Company or an Affiliate and the Participant, or if such agreement does not define “Cause,” then “Cause” shall mean the occurrence of any of the following, as determined by the Committee in its sole discretion:
|
|
(a)
|
a Participant’s willful and continued failure substantially to perform his or her duties (other than as a result of total or partial incapacity due to physical or mental illness or as a result of termination by such Participant for Good Reason), which failure continues for more than 30 days after receipt by the Participant of written
|
|
(b)
|
any willful act or omission by a Participant constituting dishonesty, fraud or other malfeasance, and any act or omission by a Participant constituting immoral conduct, which in any such case is injurious to the financial condition or business reputation of the Company or any of its Affiliates;
|
|
(c)
|
a Participant’s indictment for a felony under the laws of the United States or any state thereof or any other jurisdiction in which the Company conducts business; or
|
|
(d)
|
a Participant’s breach of any nonsolicitation, noncompetition, confidentiality, or other restrictive covenant by which he or she is bound.
|
|
(a)
|
Any Person or “group” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) that is not the Majority Shareholder is or becomes the “beneficial owner” (as defined below), directly or indirectly, of securities representing either (i) more than 50% of the combined voting power of the Company’s then outstanding securities, or (ii) 20% or more of the combined voting power of the Company’s then outstanding securities at a time when the Majority Shareholder hold less than 30% of such combined voting power. For purposes of this clause (a), “beneficial owner” has the meaning given that term in Rule 13d-3 under the Exchange Act, except that a Person shall be deemed to be the “beneficial owner” of all shares that any such Person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants, options or otherwise, without regard to the 60-day period referred to in such Rule;
|
|
(b)
|
Individuals who constitute the Board on the First Restatement Effective Date (the “Incumbent Board”) cease for any reason to constitute at least a majority thereof, provided, that any Person becoming a director subsequent to such date whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least three-quarters of the directors then comprising the Incumbent Board shall be, for purposes of this clause (b), considered as though such Person were a member of the Incumbent Board; and provided, further, that this clause (b) shall not apply as long as the Majority Shareholder is the beneficial owner of a majority of voting power of the Company’s outstanding securities;
|
|
(c)
|
The Majority Shareholder enters into any joint venture, joint operating arrangement, partnership, standstill agreement or other arrangement similar to any of the foregoing with any other Person or group, pursuant to which such Person or group assumes significant operational or managerial control of the Company; or
|
|
(d)
|
The shareholders of the Company approve a plan or agreement providing (i) for a merger or consolidation of the Company other than with a wholly owned subsidiary and other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or (ii) for a sale, exchange or other disposition of all or substantially all of the business or assets of the Company. If any of the events enumerated in this clause (d) occurs, the Board shall determine the effective date of the Change in Control resulting therefrom for purposes of this Plan.
|
|
2.8
|
“Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time.
|
|
2.9
|
“Committee” means the Remuneration and Nominating Committee of the Board or any successor committee with responsibility for compensation, or any subcommittee, as long as the number of Committee members and their qualifications shall at all times be sufficient to meet the independence requirements of the New York Stock Exchange, Inc. or any other applicable exchange on which the Company’s common equity is at the time
|
|
2.10
|
“Company” means Coty Inc., a Delaware corporation, and any successor thereto as provided in Section 16.1.
|
|
2.11
|
“Designated Beneficiary” means the Person or Persons the Participant designates from time to time on a signed form prescribed by the Committee, properly filed with the Committee during the Participant’s lifetime, as the beneficiary of any amounts or benefits the Participant owns or is to receive under the Plan, in accordance with Section 12.1. A properly filed beneficiary designation will revoke all prior designations by the same Participant. If no such form has been filed with the Committee, the Designated Beneficiary shall be the beneficiary named by the Participant in the Company’s qualified 401(k) savings plan or, if none, the Beneficiary’s estate.
|
|
2.12
|
“Director” means a member of the board of directors of the Company or an Affiliate.
|
|
2.13
|
“Disability” means either (i) disability as defined for purposes of the Company’s disability benefit plan, or (ii) a Participant’s inability, as a result of physical or mental incapacity, to perform the duties of his or her position(s) for a period of six consecutive months or for an aggregate of six months in any consecutive 12-month period. Any question as to the existence of the Disability of a Participant as to which the Participant and the Company cannot agree shall be determined in writing by a qualified independent physician mutually acceptable to the Participant and the Company. If the Participant and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such determination in writing. The determination of Disability made in writing to the Company and the Participant shall be final and conclusive for all purposes of the Plan. Following a Change in Control, the Company shall pay all expenses incurred in the determination of whether a Participant is disabled.
|
|
2.14
|
“Employee” means an employee of the Company or an Affiliate (that is not a Joint Venture).
|
|
2.15
|
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.
|
|
2.16
|
“Executive Officer” means any Company employee who is an “executive officer” as defined in Rule 3b-7 promulgated under the Exchange Act.
|
|
2.17
|
“Exercise Date” shall mean any Business Day.
|
|
2.18
|
“Exercise Price” means the price at which a Participant may purchase a Share pursuant to a Stock Option or Stock Appreciation Right.
|
|
2.19
|
“Fair Market Value” as it relates to a Share means, unless otherwise determined by the Committee, the most recent closing price of a Share on the principal national securities exchange on which the Shares are then listed, or if there were no sales on such date, on the next preceding day on which there were sales, or if such Shares are not listed on a national securities exchange, the last reported bid price in the over-the-counter market.
|
|
2.20
|
“First Restatement Effective Date” means the date on which the Amended and Restated Certificate of Incorporation of the Company that was adopted by the Company in connection with the first underwritten public offering of the Company’s common stock was filed with the Secretary of State of the State of Delaware.
|
|
2.21
|
“Good Reason” shall have the meaning set forth in any employment, severance or other agreement between the Company or an Affiliate and the Participant. If there is no employment, severance or other agreement between the Company or an Affiliate and the Participant, or if such agreement does not define “Good Reason,” then “Good Reason” shall mean the occurrence of any of the following:
|
|
(a)
|
Before a Change in Control:
|
|
(i)
|
A Participant’s removal from, or the Company’s failure to reelect or reappoint the Participant to, his or her positions at the Company (other than as a result of a promotion). For purposes of this clause (i), a mere change of title shall not constitute removal from, or non-reelection to, such position, provided that a Participant’s new title is substantially equivalent to the Participant’s title as of the Grant Date and his or her position is otherwise not adversely affected; or
|
|
(ii)
|
The relocation of a Participant’s principal workplace without his or her consent to a location more than 25 miles distant from its current location.
|
|
(b)
|
Following a Change in Control:
|
|
(i)
|
Any of the events described in clause (a) above;
|
|
(ii)
|
A material diminution in a Participant’s title, position, duties or responsibilities, or the assignment to a Participant of duties that are inconsistent, in a material respect, with the scope of duties and responsibilities associated with his or her position as of the Grant Date; or
|
|
(iii)
|
The failure of the Company to continue a Participant’s participation in the Company’s Annual Performance Plan and in this Plan or any successor plans thereto on a basis that is commensurate with his or her position.
|
|
2.22
|
“Grant Date” means the date on which an Award is granted.
|
|
2.23
|
“Joint Venture” has the meaning given that term in Section 6.9.
|
|
2.24
|
“Majority Shareholder” means (i) the Company’s majority shareholder as of the First Restatement Effective Date or (ii) a Benckiser Permitted Holder as defined in the Company’s Certificate of Incorporation effective on the First Restatement Effective Date or any other similarly situated Person as determined by the Committee.
|
|
2.25
|
“Original Effective Date” means November 8, 2012.
|
|
2.26
|
“Other Stock-Based Awards” has the meaning given that term in Section 10.
|
|
2.27
|
“Owned Shares” means Shares that a Participant has acquired through the exercise of a Stock Option or a Stock Appreciation Right, the vesting of Restricted Stock, the settlement of a Restricted Stock Unit or a distribution of Shares in connection with an Other Stock-Based Award.
|
|
2.28
|
“Participant” means an Employee selected by the Committee to receive an Award under the Plan pursuant to Section 5.2, or who has an outstanding Award granted under the Plan.
|
|
2.29
|
“Performance Award” means a right to receive cash or Shares (as determined by the Committee) upon the achievement, in whole or in part, of the applicable Performance Criteria pursuant to Section 9. A grant of Restricted Stock, Restricted Stock Units, or Other Stock Awards may be designed to qualify as Performance Awards.
|
|
2.30
|
“Performance-Based Exception” means the performance-based exception from the tax deductibility limitations of Code Section 162(m) and any regulations promulgated thereunder.
|
|
2.31
|
“Performance Criteria” means the objectives established by the Committee for a Performance Period for the purpose of determining the extent to which an Award of Performance Awards has been earned. “Performance Criteria” may be based on the relative or comparative attainment of one or more of the following criteria during a Performance Period, whether in absolute terms or relative to the performance of one or more similarly situated companies or a published index covering the performance of a number of companies: total stockholder return (inclusive or exclusive of dividends paid); stock price; gross, operating or net earnings or margins; approved rate increases; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization (“EBITDA”); EBITDA excluding traditional working media; earnings per share; economic value added; ratio of operating earnings to capital spending; net sales; sales growth; return on assets, capital or equity; income; market share; level of expenses; revenue; revenue growth; cash flow; increases in customer base; capital expenditures; cost reductions and expense control objectives; compliance with environmental or regulatory goals or requirements; conservation; budget objectives; working capital; mergers, acquisitions and divestitures; attainment of objectives measured in terms of quality or safety; customer complaints or customer satisfaction; and improvements in financial controls; and, in the case of persons who are not Executive Officers, such other criteria as may be determined by the Committee. Performance Criteria may be established on a Company-wide basis or with respect to one or more business units, divisions, subsidiaries, or geographic locations, or on an individual basis.
|
|
2.32
|
“Performance Period” means the 12-month time period during which Performance Criteria must be met in order for a Participant to earn Performance Awards granted under Section 9 or any other period established by the Committee during which Performance Criteria must be met in order for a Participant to earn Performance Awards granted under Section 9.
|
|
2.33
|
“Person” means any individual, partnership, corporation, limited liability company, association, joint stock company, trust, joint venture, unincorporated organization and any other entity, whether foreign or domestic, including any governmental entity or any department, agency or political subdivision thereof.
|
|
2.34
|
“Plan” means this Coty Inc. Equity and Long-Term Incentive Plan, as amended from time to time.
|
|
2.35
|
“Prior Plans” means the Coty Inc. Long-Term Incentive Plan and the Coty Inc. Executive Ownership Plan, each as in effect immediately prior to the Original Effective Date and as may be amended from time to time.
|
|
2.36
|
“Restricted Stock” means a contingent grant of Shares awarded to a Participant pursuant to Section 8.
|
|
2.37
|
“Restricted Stock Unit” means a Restricted Stock Unit granted to a Participant, as described in Section 8.
|
|
2.38
|
“Restriction Period” means the period during which the transfer of Restricted Stock is limited in some way (based on the passage of time, the achievement of performance objectives, or the occurrence of other events as the Committee determines, in its sole discretion) and, except as provided in the Terms and Conditions, during which the Restricted Stock and any Restricted Stock Unit is not vested.
|
|
2.39
|
“Retirement” means a termination of Service (other than a termination of Service for Cause):
|
|
(a)
|
after attaining age 60, but only if the Company or the employing Affiliate consents to the treatment of such termination as a “Retirement” for purposes of this Plan; or
|
|
(b)
|
qualifying as a retirement at normal retirement age under the laws and/or arrangements applicable to the Participant, as reasonably determined by the Committee.
|
|
2.40
|
“Section 162(m)” means Section 162(m) of the Code and the applicable regulations and other legal authority promulgated thereunder.
|
|
2.41
|
“Section 409A” means Section 409A of the Code and the applicable regulations and other legal authority promulgated thereunder.
|
|
2.42
|
“Service” means the provision of services in the capacity of an Employee or Continuing Director of the Company or an Affiliate. A transfer of Service from the Company to an Affiliate or from an Affiliate to the
|
|
2.43
|
“Share” means a share of the Class A Common Stock, par value $.01 per share, of the Company, or such other securities of the Company as may be designated by the Committee from time to time.
|
|
2.44
|
“Stock Appreciation Right” or “SAR” means an Award consisting of a right to receive any excess in value of shares of common stock over the exercise price and designated as an SAR pursuant to the terms of Section 7.
|
|
2.45
|
“Stock Appreciation Right Spread” means the amount by which the Fair Market Value, as of the Exercise Date, of the Shares as to which a Stock Appreciation Right is exercised exceeds the aggregate Exercise Price with respect to such Stock Appreciation Right.
|
|
2.46
|
“Stock Option” means a nonqualified stock option, as described in Section 6, that is not intended to meet the requirements of Code Section 422.
|
|
2.47
|
“Stock Option Spread” means the amount by which the Fair Market Value, as of the Exercise Date, of the Shares as to which a Stock Option is exercised exceeds the aggregate Exercise Price with respect to such Shares.
|
|
2.48
|
“Successor” means the Participant’s spouse, the Participant’s lineal descendants, any trust the beneficiaries of which consist only of the Participant, the Participant’s spouse and/or the Participant’s lineal descendants, or to a corporation in which the Participant, the Participant’s spouse and/or the Participant’s lineal descendants own 100% of the economic interest and has the unfettered right to prevent further transfer or disposition of the Restricted Stock, Stock Option, Stock Appreciation Right, Restricted Stock Unit or Owned Shares, applicable. The Committee may, in its discretion, deem other parties to qualify as a Successor for purposes of this Plan.
|
|
2.49
|
“Terms and Conditions” means any electronic or written agreement or other instrument or document evidencing an Award.
|
|
2.50
|
“Third Restatement Effective Date” means the date on which the Company’s stockholders approve this third amendment and restatement of the Plan.
|
|
2.51
|
“Valuation Date” means any Business Day. A Valuation Date shall also occur upon the consummation of a transaction constituting a Change in Control.
|
|
2.52
|
“Withholding Tax” means the aggregate federal, state and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising under the Plan.
|
|
3.1
|
Plan Administration. The Plan shall be administered by the Committee.
|
|
3.2
|
Authority of the Committee. Except as limited by law or the by-laws of the Company, and subject to the provisions of the Plan, the Committee shall have full power and discretion to: (a) select eligible Employees to participate in the Plan; (b) determine the size and type of Awards; (c) determine the terms and conditions of Awards in a manner consistent with the Plan; (d) determine whether, to what extent, and under what circumstances Awards may be settled or exercised in Shares, and the method or methods by which Awards may be settled or exercised; (e) determine the Fair Market Value of a Share; (f) construe and interpret the Plan and any agreement or instrument entered into under the Plan; (g) establish, amend or waive rules and regulations for the Plan’s administration; (h) specify the Exercise Price; and (i) subject to the provisions of Section 15.1, amend the terms and conditions of any outstanding Award to the extent the amended terms are within the Committee’s authority under the Plan. Further, the Committee shall make all other determinations that may
|
|
3.3
|
Decisions Binding. All determinations and decisions made by the Committee or by a Person or Persons delegated authority by the Committee pursuant to the provisions of the Plan shall be final, conclusive and binding on all Persons, including, without limitation, the Company, its shareholders, all Affiliates, Employees, Participants and their estates and beneficiaries.
|
|
4.1
|
Number of Shares Available for Grants. Subject to adjustment as provided in Sections 4.2 and 4.3, the number of Shares that may be issued or transferred to Participants under the Plan is [ ]. No additional awards shall be made under the Prior Plans on or after the Original Effective Date. Subject to adjustment as provided in Section 4.3, to the extent necessary to comply with Section 162(m), the maximum number of Shares or Share equivalent units that may be granted during any fiscal year to any one Participant under Options, SARs, Restricted Stock, Restricted Stock Units, Performance Awards or other Stock-Based Awards is $25,000,000, which limit will (i) be calculated based on the Fair Market Value of the number of Shares subject to the applicable Award as of the applicable Grant Date and (ii) apply regardless of whether the compensation is paid in Shares or in cash. To the extent necessary to comply with Code Section 162(m) the maximum aggregate dollar amount that may be paid to any one Participant during any fiscal year under Performance Awards or any cash-based Award under Section 9 is $25,000,000.
|
|
4.2
|
Lapsed Awards. If any Award granted under this Plan or a Prior Plan is canceled, terminates, expires or lapses for any reason, any Shares subject to such award will again be available for the grant of an Award under the Plan. Common Stock issued through the assumption or substitution of outstanding grants from an acquired company shall not reduce the shares available for Awards under the Plan. In addition, if a Share subject to an Award is not delivered because the Award is settled in cash, then that Share will thereafter be deemed to be available for grant. If a Share subject to an Award is not delivered because it is used to satisfy a tax withholding obligation or used to pay the Exercise Price of an Option, then that Share will not thereafter be deemed to be available for grant.
|
|
4.3
|
Adjustments in Authorized Shares. If the Shares, as currently constituted, are changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether because of a merger, consolidation, recapitalization, reclassification, split, reverse split, combination of shares, or otherwise, but not including a capital infusion from any source) or if the number of Shares is increased through the payment of a stock dividend, then the Committee shall substitute for or add to each Share that may become subject to an Award the number and kind of shares of stock or other securities into which each outstanding Share was changed, for which each such Share was exchanged, or to which each such Share is entitled, as the case may be.
|
|
4.4
|
Sources of Shares Deliverable under Awards. Any Shares delivered pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares or of treasury Shares.
|
|
5.1
|
Eligibility. Any Employee, including any officer or employee-director of the Company or an Affiliate, shall be eligible to be designated a Participant. To be eligible, a Participant shall have signed and delivered to the Company the Confidentiality and Non-Competition Agreement delivered by the Company to the Participant.
|
|
5.2
|
Actual Participation. The Committee shall determine the eligible Employees to whom it will grant Awards.
|
|
6.1
|
Grant of Stock Options.
|
|
(a)
|
Subject to the terms and provisions of the Plan, the Committee may grant Stock Options to any Participant in the number, and upon the terms, and at such time or times, as the Committee determines and sets forth in the Terms and Conditions.
|
|
(b)
|
Each Stock Option grant shall be evidenced by the Terms and Conditions that specifies the duration of the Stock Option, the number of Shares to which the Stock Option pertains, the manner, time, and rate of exercise and vesting of the Stock Option, and such other provisions as the Committee determines. Vesting conditions may include, but not be limited to, the achievement of specific performance objectives (Company-wide, business unit, and/or individual) or continued Service.
|
|
6.2
|
Exercise Price. The Terms and Conditions shall specify the Stock Option’s Exercise Price, which shall be not less than the Fair Market Value of a Share on the Grant Date.
|
|
6.3
|
Duration of Stock Options. Each Stock Option will expire at the time determined by the Committee at the time of grant and set forth in the Terms and Conditions.
|
|
6.4
|
Exercise of Stock Options.
|
|
(a)
|
Stock Options shall become exercisable at such times and be subject to such vesting and other restrictions and conditions as the Committee in each instance approves and sets forth in each Terms and Conditions. Restrictions and conditions on the exercise of a Stock Option need not be the same for each Award or for each Participant.
|
|
(b)
|
The holder of a Stock Option may exercise the Stock Option only by delivering a written notice of exercise to the Company setting forth the number of Shares as to which the Stock Option is to be exercised. Upon the Exercise Date, the holder shall pay or provide for the Exercise Price and applicable Withholding Tax in full, pursuant to such procedures established by the Committee from time to time after giving consideration to applicable tax, securities and accounting rules.
|
|
(c)
|
Any exercisable Stock Option that has not been exercised by its holder shall be automatically exercised in accordance with subsection (b) hereof on the Exercise Date immediately prior to its expiration if, on such Exercise Date, there is a Stock Option Spread with respect to such Stock Option.
|
|
6.5
|
Termination of Service. Except as otherwise provided in the Terms and Conditions:
|
|
(a)
|
In the event a Participant’s Service terminates by reason of death, Disability, or Retirement:
|
|
(i)
|
The Applicable Fraction of the portion of any Stock Option held by such Participant which has not theretofore become exercisable shall immediately become vested and exercisable.
|
|
(ii)
|
All Stock Options held by the Participant, to the extent exercisable (including by application of clause (i) above) as of the Participant’s termination of Service shall remain exercisable through the second anniversary of the date of termination of Service and shall thereafter expire.
|
|
(iii)
|
Any unvested portion of the Participant’s Stock Options as of the date of termination (other than any portion thereof that becomes vested pursuant to clause (i) above) shall be forfeited and canceled, without consideration, on the date of termination.
|
|
(b)
|
Except as provided in Section 6.8, in the event a Participant’s Service terminates other than by reason of death, Disability, or Retirement:
|
|
(i)
|
Any unvested portion of the Participant’s Stock Options as of the date of termination shall be forfeited and canceled on the date of termination, and
|
|
(ii)
|
The vested portion, if any, of the Participant’s Stock Options shall remain exercisable through (i) the ninetieth (90th) day after the Participant’s termination of Service, if the ninety (90) day period commences in an open trading window, or (ii) if the ninety (90) day period commences in a closed trading window, the ninetieth (90th) day commencing from the first day of the next open trading window. Any vested Stock Option remaining outstanding after such date shall thereafter expire.
|
|
(c)
|
Notwithstanding the foregoing, the Committee may, in its sole discretion, accelerate the vesting and exercisability, and/or extend the period of exercisability, of all or a portion of a Stock Option at any time as permitted by Section 409A.
|
|
(d)
|
In no event shall a Stock Option be exercisable following its expiration date.
|
|
6.6
|
Nontransferability of Stock Options.
|
|
(a)
|
Except as otherwise provided in Section 6.6(b), a Participant’s Terms and Conditions, or the Plan, during the Restriction Period, (i) no Stock Option granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, and (ii) all Stock Options shall be exercisable during the Participant’s lifetime only by the Participant or his or her guardian or legal representative. The Committee may, in its sole discretion, require a Participant’s guardian or legal representative to supply it with the evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Participant.
|
|
(b)
|
Subject to applicable law, vested Stock Options may be transferred to a Successor. Such transferred Stock Options may only be further sold, transferred, pledged, assigned or otherwise alienated by the Successor in accordance with this Section 6.6, and shall be subject in all respects to the terms of the Terms and Conditions and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such other evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan.
|
|
6.7
|
Dividend Equivalents and Other Distributions. The Committee may, in its sole discretion, provide under an agreement for payments in connection with Stock Options that are equivalent to dividends or other distributions declared and paid on the Shares underlying the Stock Options prior to the date of exercise. Such dividend equivalent agreement, if any, shall be separate and apart from the Terms and Conditions and shall be designed to comply separately with Section 409A.
|
|
6.8
|
Change in Control. If, within twelve months following a Change in Control, (i) a Participant is terminated by the Company or an employing Affiliate (that is not a Joint Venture) without Cause or (ii) such Participant resigns from the Company or an employing Affiliate (that is not a Joint Venture) for Good Reason, the unvested portion of any then outstanding Stock Option shall vest and become exercisable.
|
|
6.9
|
Employment in a Joint Venture. If a Participant becomes an employee of certain joint ventures of the Company, as determined by the Board from time to time (a “Joint Venture”), during the Restriction Period, vesting of the Participant’s Stock Options shall be tolled beginning on the date such Participant becomes an employee of the Joint Venture until the date such Participant again becomes an Employee. Accordingly, the Restriction Period for such Participant’s Stock Options shall be extended by the number of days the Participant was an employee of the Joint Venture.
|
|
7.1
|
Grant of Stock Appreciation Rights.
|
|
(a)
|
Subject to the terms and provisions of the Plan, the Committee may grant Stock Appreciation Rights to any Participant in the number, and upon the terms, and at such time or times, as the Committee determines and sets forth in the Terms and Conditions.
|
|
(b)
|
Each Stock Appreciation Right grant shall be evidenced by the Terms and Conditions that specifies the duration of the Stock Appreciation Right, the number of Shares to which the Stock Appreciation Right pertains, the manner, time, and rate of exercise and vesting of the Stock Appreciation Right, and such other provisions as the Committee determines. Vesting conditions may include, but not be limited to, the achievement of specific performance objectives (Company-wide, business unit, and/or individual) or continued Service.
|
|
7.2
|
Exercise Price. The Terms and Conditions shall specify the Stock Appreciation Right’s Exercise Price, which shall be not less than the Fair Market Value of a Share on the Grant Date.
|
|
7.3
|
Duration of Stock Appreciation Rights. Each Stock Appreciation Right will expire at the time determined by the Committee at the time of grant and set forth in the Terms and Conditions.
|
|
7.4
|
Exercise of Stock Appreciation Rights.
|
|
(a)
|
Stock Appreciation Rights shall become exercisable at such times and be subject to such vesting and other restrictions and conditions as the Committee in each instance approves and sets forth in each Terms and Conditions. Restrictions and conditions on the exercise of a Stock Appreciation Right need not be the same for each Award or for each Participant.
|
|
(b)
|
The holder of a Stock Appreciation Right may exercise the Stock Appreciation Right only by delivering a written notice of exercise to the Company setting forth the number of Stock Appreciation Rights to be exercised. The Stock Appreciation Right Spread may be settled, as set forth in the Terms and Conditions, by delivery by the Company of the number of Shares equal to the Stock Appreciation Right Spread, in which case the Participant shall on or before the Exercise Date pay or provide for the applicable Withholding Tax in full, pursuant to such exercise procedures established by the Committee from time to time after giving consideration to applicable tax, securities and accounting rules. Any exercisable Stock Appreciation Right that has not been exercised by its holder shall be automatically exercised in accordance with subsection (b) hereof on the Exercise Date immediately prior to its expiration if, on such Exercise Date, there is a Stock Appreciation Right Spread with respect to such Stock Appreciation Right.
|
|
7.5
|
Termination of Service. Except as otherwise provided in the Terms and Conditions:
|
|
(a)
|
In the event a Participant’s Service terminates by reason of death, Disability, or Retirement:
|
|
(i)
|
The Applicable Fraction of the portion of any Stock Appreciation Right held by such Participant which has not theretofore become exercisable shall immediately become vested and exercisable.
|
|
(ii)
|
All Stock Appreciation Rights held by the Participant, to the extent exercisable (including by application of clause (i) above) as of the Participant’s termination of Service shall remain exercisable through the second anniversary of the date of termination of Service and shall thereafter expire.
|
|
(iii)
|
Any unvested portion of the Participant’s Stock Appreciation Rights as of the date of termination (other than any portion thereof that becomes vested pursuant to clause (i) above) shall be forfeited and canceled, without consideration, on the date of termination.
|
|
(b)
|
Except as provided in Section 7.8, in the event a Participant’s Service terminates other than by reason of death, Disability, or Retirement:
|
|
(i)
|
Any unvested portion of the Participant’s Stock Appreciation Rights as of the date of termination shall be forfeited and canceled on the date of termination, and
|
|
(ii)
|
The vested portion, if any, of the Participant’s Stock Appreciation Rights shall remain exercisable through the ninetieth (90th) day after the Participant’s termination of Service. Any vested Stock Appreciation Right remaining outstanding after such date shall thereafter expire.
|
|
(c)
|
Notwithstanding the foregoing, the Committee may, in its sole discretion, accelerate the vesting and exercisability, and/or extend the period of exercisability, of all or a portion of a Stock Appreciation Right at any time as permitted by Section 409A.
|
|
(d)
|
In no event shall a Stock Appreciation Right be exercisable following its expiration date.
|
|
7.6
|
Nontransferability of Stock Appreciation Rights.
|
|
(a)
|
Except as otherwise provided in Section 7.6(b), a Participant’s Terms and Conditions, or the Plan, during the Restriction Period, (i) no Stock Appreciation Right granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, and (ii) all Stock Appreciation Rights shall be exercisable during the Participant’s lifetime only by the Participant or his or her guardian or legal representative. The Committee may, in its sole
|
|
(b)
|
Subject to applicable law, vested Stock Appreciation Rights may be transferred to a Successor. Such transferred Stock Appreciation Rights may only be further sold, transferred, pledged, assigned or otherwise alienated by the Successor in accordance with this Section 7.6, and shall be subject in all respects to the terms of the Terms and Conditions and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such other evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan.
|
|
7.7
|
Dividend Equivalents and Other Distributions. The Committee may, in its sole discretion, provide under an agreement for payments in connection with Stock Appreciation Rights that are equivalent to dividends and other distributions declared and paid on the Shares underlying the Stock Appreciation Rights prior to the date of exercise. Such dividend equivalent agreement, if any, shall be separate and apart from the Terms and Conditions and shall be designed to comply separately with Section 409A.
|
|
7.8
|
Change in Control. If, within twelve months following a Change in Control, (i) a Participant is terminated by the Company or an employing Affiliate (that is not a Joint Venture) without Cause or (ii) such Participant resigns from the Company or an employing Affiliate (that is not a Joint Venture) for Good Reason, the unvested portion of any then outstanding Stock Appreciation Right shall vest and become exercisable.
|
|
7.9
|
Employment in a Joint Venture. If a Participant becomes an employee of certain joint ventures of the Company, as determined by the Board from time to time (a “Joint Venture”), during the Restriction Period, vesting of the Participant’s Stock Appreciation Rights shall be tolled beginning on the date such Participant becomes an employee of the Joint Venture until the date such Participant again becomes an Employee. Accordingly, the Restriction Period for such Participant’s Stock Appreciation Rights shall be extended by the number of days the Participant was an employee of the Joint Venture.
|
|
8.1
|
Grant of Restricted Stock and Restricted Stock Units. Subject to the terms and provisions of the Plan, the Committee may, at any time and from time to time, grant Restricted Stock or Restricted Stock Units to any Participant in such amounts as it determines and sets forth in the Terms and Conditions.
|
|
8.2
|
Terms and Conditions. Each grant of Restricted Stock or Restricted Stock Units shall be evidenced by the Terms and Conditions that specifies the Restriction Period, the number of Shares or Restricted Stock Units granted, the purchase price, if any, and such other provisions as the Committee determines.
|
|
8.3
|
Nontransferability.
|
|
(a)
|
Except as provided in Section 8.3(b), during the Restricted Period, (i) no Restricted Stock or Restricted Stock Unit granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution and (ii) all rights with respect to Restricted Stock or Restricted Stock Units shall be available during the Participant’s lifetime only to the Participant or the Participant’s guardian or legal representative. The Committee may, in its sole discretion, require a Participant’s guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of the Participant.
|
|
(b)
|
Subject to applicable law, Restricted Stock may be transferred to a Successor. Such transferred Restricted Stock may only be further sold, transferred, pledged, assigned or otherwise alienated by the Successor in accordance with this Section 8.3, and shall be subject in all respects to the terms of the Terms and Conditions and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such other evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan.
|
|
8.4
|
Termination of Service. Except as provided in Section 8.5, if a Participant’s Service terminates, then except as otherwise provided in the Terms and Conditions all unvested Restricted Stock and Restricted Stock Units held by such Participant will be forfeited and any vested Restricted Stock and Restricted Stock Units shall continue to be subject to the terms of the Plan and any applicable Award.
|
|
8.5
|
Change in Control. If, within twelve months following a Change in Control, (i) a Participant is terminated by the Company or an employing Affiliate (that is not a Joint Venture) without Cause or (ii) such Participant resigns from the Company or an employing Affiliate (that is not a Joint Venture) for Good Reason, all then outstanding Restricted Stock and Restricted Stock Units shall vest and become nonforfeitable.
|
|
8.6
|
Other Conditions. The Committee may impose such other conditions and restrictions on any Restricted Stock and Restricted Stock Units as it deems advisable and sets forth in the Terms and Conditions, including, without limitation, vesting restrictions based upon the achievement of specific performance objectives (Company-wide, business unit, and/or individual) or continued Service, and/or restrictions under applicable federal or state securities laws. The Committee may provide that restrictions established under this Section 8.6 as to any given Award will lapse all at once or in installments.
|
|
8.7
|
Voting Rights. Except as otherwise provided in the Terms and Conditions, and subject to Section 13.1(c), a Participant holding Shares of Restricted Stock may exercise any voting rights that apply to those Shares during the Restriction Period.
|
|
8.8
|
Dividends and Other Distributions. During the Restriction Period, a Participant holding Shares of Restricted Stock or Restricted Stock Units shall be credited with regular dividends or dividend equivalents and other distributions paid on those Shares. Such dividends or dividend equivalents and other distributions shall be subject to the same vesting conditions as the underlying Shares or Restricted Stock Units, and shall be paid within 30 days following the end of the Restriction Period.
|
|
8.9
|
Section 83(b) Elections on Restricted Stock. The Participant, if subject to taxation in the United States with respect to any compensation derived under the Plan, shall indicate to the Company whether the Participant intends to make an election under Code Section 83(b) with respect to the Restricted Stock.
|
|
8.10
|
Employment in a Joint Venture. If a Participant becomes an employee of a Joint Venture during the Restriction Period, vesting of the Participant’s Restricted Stock and Restricted Stock Units shall be tolled beginning on the date such Participant becomes an employee of the Joint Venture and shall recommence on the date such Participant again becomes an Employee. Accordingly, the Restriction Period for such Participant’s Restricted Stock and Restricted Stock Units shall be extended by the number of days the Participant was an employee of the Joint Venture.
|
|
8.11
|
Payment of Restricted Stock Units. Each Restricted Stock Unit shall be payable to the Participant in such form provided in the Terms and Conditions following the last day of the Restriction Period, or on such later date provided in the Terms and Conditions or pursuant to a deferral agreement between the Participant and the Company.
|
|
9.1
|
Grant of Performance Awards. The Committee shall have the authority to determine (i) the Participants who shall receive Performance Awards, (ii) the size, number, amount or value, as applicable, of Performance Awards, and (iii) the Performance Criteria applicable in respect of such Performance Awards for each Performance Period. The Committee shall determine the duration of each Performance Period (which may differ from each other), and there may be more than one Performance Period in existence at any one time as to any Participant or all or any class of Participants. Each grant of Performance Awards shall be evidenced by the Terms and Conditions that shall specify the Performance Criteria applicable thereto and such other terms and conditions not inconsistent with the Plan as the Committee shall determine.
|
|
9.2
|
Earning of Performance Awards. The grant and/or vesting of Performance Awards shall be contingent, in whole or in part, upon the attainment of specified Performance Criteria or the occurrence of any event or events involving a Change in Control, death or Disability, as the Committee shall determine. In addition to the
|
|
9.3
|
Performance Awards and Code Section 162(m). The provisions of this Section 9.3 shall apply with respect to any Performance Award that is intended to meet the Performance-Based Exception.
|
|
(a)
|
Establishment of Performance Criteria. The Committee shall establish the Performance Criteria for the applicable Performance Period no later than the 90th day after the Performance Period begins (or by such other date as may be required under Section 162(m)) but in any event at a time when achievement of the Performance Criteria is substantially uncertain. The Committee may not in any event increase the amount of compensation payable to an Executive Officer upon attainment of the Performance Criteria above the maximum amount approved by the Committee at the time the Performance Criteria is established.
|
|
(b)
|
Certification of Attainment of Performance Criteria. As soon as practicable after the end of a Performance Period and prior to any payment in respect of such Performance Period, the Committee shall certify in writing the amount, number or value, as applicable, of the Performance Awards that have been earned on the basis of performance in relation to the established Performance Criteria.
|
|
(c)
|
Payment of Awards. Earned Performance Awards shall be distributed to the Participant or, if the Participant has died, to the Participant’s Designated Beneficiary as soon as practicable after the expiration of the Performance Period and the Committee’s certification under Section 9.3(b) above, provided that, unless the payment of a Performance Award has been deferred in accordance with Section 409A of the Code, distributions of a Performance Award shall be made no later than March 15 of the year following the year in which the amount is earned.
|
|
10.1
|
The Committee shall have authority to grant to eligible Participants an “Other Stock-Based Award,” which shall consist of any right which (i) is not a Stock Option, Stock Appreciation Right, Restricted Stock Unit or Restricted Stock and (ii) is an Award of Shares or an Award denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares (including, without limitation, securities convertible into Shares), as deemed by the Committee to be consistent with the purposes of the Plan. Subject to the terms of the Plan and any applicable Terms and Conditions, the Committee shall determine the terms and conditions of any such Other Stock-Based Award.
|
|
11.1
|
Restrictions. The Committee may impose such restrictions on any Shares as it deems necessary or advisable, including, without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which the Shares are then listed and/or traded, and under any blue sky or state securities laws.
|
|
11.2
|
Additional Conditions of Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or transferred, or (ii) to treat as owner of such Shares, to accord the right to vote as such owner, or to pay dividends to any transferee to whom such Shares have been transferred in violation of the Plan or any Terms and Conditions.
|
|
12.1
|
Each Participant may, from time to time, name any Designated Beneficiary (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case the Participant should die before receiving any or all of his or her benefits under the Plan. Each beneficiary designation shall revoke all prior designations by the same Participant, must be in a form prescribed by the Committee and must be made during the Participant’s lifetime.
|
|
13.1
|
The Terms and Conditions may provide that if the Participant breaches, whether during or after termination of Service, a nonsolicitation, noncompetition, confidentiality, or other restrictive covenant by which he or she is bound, then in addition to any other penalties or restrictions that may apply under any such agreement, state law, or otherwise, the Participant shall forfeit:
|
|
(a)
|
Any Awards granted to him or her under the Plan, including Awards that have become exercisable;
|
|
(b)
|
The profit the Participant realized from the exercise of any Stock Options or Stock Appreciation Rights that the Participant exercised after terminating Service and within the six-month period immediately preceding the Participant’s termination of Service, which is the Stock Option Spread or Stock Appreciation Right Spread associated with any Shares acquired by the Participant upon his or her exercise of such Stock Options or such Stock Appreciation Rights; and
|
|
(c)
|
The Fair Market Value, as determined on the vesting date, of any Restricted Stock that vested or Restricted Stock Unit that was settled within the six-month period immediately preceding the Participant’s termination of Service.
|
|
14.1
|
Service. Nothing in the Plan shall interfere with or limit in any way the right of the Company or any Affiliate to terminate any Participant’s Service at any time, or confer upon any Participant any right to continue in the Service of the Company or any Affiliate. The grant of any Award under the Plan shall not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.
|
|
14.2
|
Participation. No Employee shall have the right to receive an Award under the Plan, or, having received any Award, to receive a future Award.
|
|
15.1
|
Amendment, Modification and Termination. The Board may at any time and from time to time alter, amend, modify or terminate the Plan in whole or in part, without the approval of the Company’s shareholders, except to the extent such approval is required by law. Subject to the terms and conditions of the Plan, the Committee may modify, extend or renew outstanding Awards under the Plan, or accept the surrender of outstanding Awards (to the extent not already exercised) and grant new Awards in substitution of them (to the extent not already exercised), in order to comply with the requirements of applicable law or otherwise. Notwithstanding the foregoing, no modification of an Award shall, without the prior written consent of the Participant, materially alter or impair any rights or obligations under any Award already granted under the Plan, except such an amendment made to comply with the requirements of applicable law.
|
|
15.2
|
Adjustment of Awards upon the Occurrence of Certain Events.
|
|
(a)
|
In General. If the Shares, as currently constituted, are changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether because of a merger, consolidation, recapitalization, reclassification, split, reverse split, combination of shares, or otherwise, but not including a capital infusion from any source) or if the number of Shares is increased through the payment of a stock dividend, then the Committee shall substitute for or add to each Share underlying an Award the number and kind of shares of stock or other securities into which each outstanding Share was changed, for which each such Share was exchanged, or to which each such Share is entitled, as the case may be, which shares or other securities shall be subject to the same terms and conditions as the underlying Award. Any such adjustment in an outstanding Stock Option or Stock Appreciation Right shall be made with a corresponding adjustment in the Exercise Price for each Share or other unit of any
|
|
(b)
|
Reciprocal Transactions. The Committee may, but shall not be obligated to, make an appropriate and proportionate adjustment to an Award or to the Exercise Price of any outstanding Award, and/or grant an additional Award to the holder of any outstanding Award, to compensate for the diminution in the intrinsic value of the Shares resulting from any reciprocal transaction.
|
|
(c)
|
Certain Unusual or Nonrecurring Events. In recognition of unusual or nonrecurring events affecting the Company or its financial statements, or in recognition of changes in applicable laws, regulations, or accounting principles, and, whenever the Committee determines that adjustments are appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, the Committee may, using reasonable care, make adjustments in the terms and conditions of, and the criteria included in, Awards. In no event will the Committee, unless otherwise approved by shareholders, be permitted (i) to reduce the Exercise Price of any outstanding Stock Option or Stock Appreciation Right, (ii) cancel a Stock Option or Stock Appreciation Right in exchange for cash or other Awards (except as provided in Section 15.4), (iii) exchange or replace an outstanding Stock Option or Stock Appreciation Right with a new Stock Option or Stock Appreciation Right with a lower Exercise Price, or (iv) take any other action that would be a “repricing” of Stock Options or Stock Appreciation Rights.
|
|
(d)
|
Notice. The Committee shall give notice of any adjustment to each Participant who holds an Award that has been adjusted and the adjustment (whether or not such notice is given) shall be effective and binding for all Plan purposes.
|
|
(e)
|
Section 409A. Notwithstanding any provision herein to the contrary, no adjustment shall be made under this Section 15.2 to the extent it would give rise to adverse tax consequences under Section 409A.
|
|
15.3
|
Fractional Shares. Fractional Shares, whether resulting from any adjustment in Awards pursuant to Section 15.2 or otherwise, may be settled in cash or otherwise as the Committee determines.
|
|
15.4
|
Change in Control.
|
|
(a)
|
If, within twelve months following a Change in Control, (i) a Participant is terminated by the Company or an employing Affiliate (that is not a Joint Venture) without Cause or (ii) such Participant resigns from the Company or an employing Affiliate (that is not a Joint Venture) for Good Reason, all then outstanding Awards shall become fully vested.
|
|
(b)
|
Any Award that has not been fully exercised before the date of a Change in Control may be settled or otherwise terminated on such date in the discretion of the Committee, unless a provision has been made in writing in connection with such transaction for the assumption of all Awards theretofore granted, or the substitution for such Awards of awards to acquire the stock of the surviving, resulting or acquiring corporation, with any adjustments as the Committee determines appropriate, in which event the Awards theretofore granted shall continue in the manner and under the terms so provided. Notwithstanding anything in the Plan to the contrary, any underwater Award that has not been fully exercised, and any Award that the Committee determines cannot become vested, before the date of consummation of the Change in Control may be canceled without consideration in the discretion of the Committee.
|
|
15.5
|
Tax Withholding. The Company shall have the right to deduct or withhold, or require a Participant to remit to the Company, an amount (either in cash or Shares) sufficient to satisfy any Withholding Tax.
|
|
16.1
|
Successors. All obligations of the Company under the Plan or any Terms and Conditions shall be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the Company’s stock, or a merger or consolidation, or otherwise.
|
|
16.2
|
Legal Construction.
|
|
(a)
|
Number. Except where otherwise indicated by the context, any plural term used in the Plan includes the singular and any singular term includes the plural.
|
|
(b)
|
Severability. If any provision of the Plan is held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.
|
|
16.3
|
Business Day. In the event the day prescribed for the performance of any act under the Plan, or deadline by which such act must be performed, shall fall on a day other than a Business Day, such day or deadline shall be extended until the close of business on the next succeeding Business Day.
|
|
16.4
|
Requirements of Law. The granting of Awards, the issuance of Shares and the payment of cash under the Plan shall be subject to all applicable laws, rules and regulations, and to any approvals by governmental agencies or national securities exchanges as may be required.
|
|
16.5
|
Rights of a Shareholder. A Participant shall not be, nor shall a Participant have any of the rights and privileges of, a shareholder until certificates for the underlying Shares have been issued or the underlying Shares have been registered as a book-entry in the name of the Participant.
|
|
16.6
|
Securities Law Compliance.
|
|
(a)
|
As to any individual who is, on the relevant date, an officer, director or greater than 10% percent beneficial owner of any class of the Company’s equity securities that is registered pursuant to Section 12 of the Exchange Act, all as defined under Section 16 of the Exchange Act, transactions under the Plan are intended to comply with all applicable conditions of Rule 16b-3 under the Exchange Act, or any successor rule. To the extent any provision of the Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by law and deemed advisable by the Committee.
|
|
(b)
|
To the extent the Committee deems it necessary, appropriate or desirable to comply with state securities laws or practice and to further the purposes of the Plan, the Committee may, without amending the Plan, (i) establish rules applicable to Awards granted to Participants, including rules that differ from those set forth in the Plan, and (ii) grant Awards to such Participants in accordance with those rules that would require the application of the securities laws of any state.
|
|
16.7
|
Unfunded Status of the Plan. The Plan is intended to constitute an “unfunded” plan for incentive compensation. With respect to any payments or deliveries of Shares not yet made to a Participant by the Company, the Participant’s rights are no greater than those of a general creditor of the Company. The Committee may authorize the establishment of trusts or other arrangements to meet the obligations created under the Plan, so long as the arrangement does not cause the Plan to lose its legal status as an unfunded plan.
|
|
16.8
|
Non-U.S. Based Participant. Notwithstanding any other provision of the Plan to the contrary, the Committee may make Awards to Participants who are not citizens or residents of the United States, or to Participants outside the United States, on terms and conditions that are different from those specified in the Plan as may, in the Committee’s judgment, be necessary or desirable to foster and promote achievement of the Plan’s purposes. In furtherance of such purposes, the Committee may, without amending the Plan, establish or modify rules, procedures and subplans as may be necessary or advisable to comply with provisions of laws in other countries or jurisdictions in which the Company operates or has employees.
|
|
16.9
|
Governing Law. To the extent not preempted by Federal law, the Plan and all agreements hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of New York, without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.
|
|
16.10
|
Section 162(m). The Plan is intended to be administered, interpreted and construed so that Performance Awards may qualify for the Performance-Based Exception.
|
|
16.11
|
Recoupment. Notwithstanding any provision in the Plan to the contrary, Awards granted or paid under the Plan will be subject to recoupment by the Company pursuant to any “clawback” or similar compensation recoupment policy that may be established by the Company.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|